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ABSTRACT 
 
Reginald D. Cannady: Alcohol Self-administration and Relapse-like Behavior: A 
Functional Role for Enhanced Activity at AMPA Receptors 
“Under the direction of Drs. Clyde Hodge and Joyce Besheer” 
 
Mechanisms underlying excessive alcohol drinking behavior and relapse are not 
fully understood and are critical for mapping the pathological course of alcohol use 
disorders (AUD). Long-term ethanol consumption results in strengthened excitatory 
neurotransmission and increased AMPA receptor signaling in animal models. However, 
the mechanistic role of enhanced AMPA receptor activity in ethanol-reinforcement and 
alcohol-seeking behavior remains unclear. Thus, the experiments in this dissertation 
sought to elucidate the behavioral and molecular mechanisms that underlie AMPA 
receptor-mediated ethanol reinforcement processes and relapse to ethanol-seeking 
behavior using a preclinical model of high alcohol preference, the alcohol-preferring (P-) 
rat. Enhancement of AMPA receptor signaling by systemically administered aniracetam 
(AMPA receptor positive allosteric modulator) significantly increased ethanol self-
administration in a reinforcer-specific manner. Moreover, aniracetam potentiated cue-
induced reinstatement in P-rats, which suggests that enhanced activity at AMPA 
receptors promotes reinforcement and ethanol-seeking behavior. Experiments further 
characterized enhanced AMPA receptor signaling in modulating operant self-
administration and relapse-like behavior by examining neuroanatomical contributions to 
AMPA receptor-mediated alterations in ethanol reinforcement. Since AMPA receptor 
activity is potentiated by post-translational modification (e.g. phosphorylation of GluA1 
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subunits), immunohistochemistry was used to examine neuroadaptive changes in 
pGluA1 in limbic brain regions after a history of ethanol self-administration. Increased 
pGluA1 immunoreactivity was observed in sub-nuclei of the amygdala and nucleus 
accumbens of ethanol self-administering P-rats relative to the sucrose controls. Guided 
by immunohistochemistry results, the effects of aniracetam on ethanol self-
administration were examined via site-specific microinjections in the amygdala and 
nucleus accumbens. Intra-amygdala, but not intra-accumbens, aniracetam increased 
ethanol self-administration in a reinforcer-specific manner. Furthermore, co-
administration of intra-amygdala aniracetam and myristolated AIP (CaMKII peptide 
inhibitor) blocked aniracetam-induced increased ethanol self-administration; which 
demonstrates a critical role for amygdala CaMKII activity in AMPA receptor-mediated 
potentiation of ethanol reinforcement. These data suggest that enhanced amygdala 
AMPA receptor activity promotes drinking and ultimately could contribute to alcohol use 
disorders. In contrast, intra-amygdala aniracetam did not significantly alter cue-induced 
reinstatement; which suggest that enhanced AMPA receptor activity in this region may 
not significantly contribute to promoting cue-induced ethanol-seeking. Collectively, key 
experimental results provide novel insight into AMPA receptor-related mechanisms in 
excessive alcohol drinking behavior and vulnerability to relapse.
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CHAPTER 1: INTRODUCTION 
 
An Overview of Alcoholism 
The consumption of alcohol by humans has been, and still is, an integral part of 
everyday life for many around the world. Throughout the course of recorded history 
there is substantial evidence of alcohol use for a variety of purposes such as 
celebrations, social and sporting events, or religious ceremonies. For most consumers 
of alcohol, the occasional indulgence is trivial and of little long-term consequence. 
However, some individuals are susceptible to the deleterious ramifications of long-term 
alcohol consumption. These individuals often chronically misuse and abuse alcohol and 
may develop an alcohol use disorder (AUD). Researchers and clinicians have long-
recognized the symptomology associated with alcohol use disorders; however, the 
etiology remains much more elusive. A fundamental understanding of the etiology of 
alcoholism/AUD is critically important and will provide novel insights into more efficient 
and effective treatment options for those suffering from this debilitating condition.    
The current criteria for diagnosing AUDs are set by the American Psychiatric 
Association and outlined in the Diagnostic and Statistics Manual for Mental Disorders: 
5th Edition (DSM-5). The DSM-5, describes AUD as, “A problematic pattern of alcohol 
use leading to clinically significant impairment or distress” (American Psychiatric 
Association, 2013). At least two of eleven established criteria must be met within a 1-
year period for an alcohol use disorder diagnosis which include (but are not limited to):  
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excessive or uncontrollable alcohol consumption, craving, tolerance, withdrawal, and 
continued use despite negative consequences (American Psychiatric Association, 
2013).  New guidelines in the recently released DMS-V merge traditional alcohol abuse- 
and alcohol dependence diagnosis, while allowing a diagnosis to be classified as mild, 
moderate, or severe based of the number of criteria met within a 1-year period. The 
changes in diagnostic criteria reflect acknowledgements by clinicians and researchers 
that AUD is a complex disorder and that the efficacy of treatments may vary due to 
severity of the disease. Moreover, the 1-year window of time to meet established criteria 
cannot be understated because it emphasizes that 1) acute intoxication episodes alone 
are not the primary cause of AUD and that 2) alcoholism is a chronically relapsing 
disorder characterized by enduring challenges to control drinking; likely the result of 
lasting alcohol-induced neurobiological maladaptations (Hansson et al., 2010; Luscher 
and Malenka, 2011). Thus, it is essential that investigators and clinicians work to identify 
the neurobiological factors that underlie chronic pathological maladaptations that trigger 
excessive alcohol drinking that could lead to alcoholism or AUD(s).   
 
Impact, Prevalence, and Risk Factors Associated with Alcohol Abuse in Humans  
Alcoholism and AUDs have a profound impact on society. In the United States 
alone, the third leading cause of preventable mortality is attributed to AUDs (Mokdad et 
al., 2004) with many other countries experiencing similar trends (Lopez et al., 2006). In 
the US over 85,000 deaths per year are the result of alcohol abuse; outnumbering 
deaths resulting from all infectious diseases combined (Mokdad et al., 2004). The 
financial burden attributed to AUDs is enormous. The estimated economic cost of 
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alcohol abuse was $223.5 billion in 2006 alone; which was calculated by factors such as 
lost productivity, healthcare costs, and criminal justice costs among others (Bouchery et 
al., 2011).  
It is estimated that the 12-month prevalence (identified symptoms in the 12 
month period) for alcohol use disorder is 8.5% and 4.7% for adults and teens (ages 12-
17), respectively (American Psychiatric Association, 2013; Hasin et al., 2007) Men 
(12.4%) typically exhibit higher 12-month prevalence of alcoholism than women (4.9%), 
and younger populations (ages 18-29) make up a majority (16.2%) of diagnosed AUD 
cases (Hasin et al., 2007) (American Psychiatric Association, 2013). Further, it is well 
established that individuals with early onset of heavy drinking during adolescence have 
increased incidence of AUD in adulthood (Dawson et al., 2008). It is no coincidence that 
younger individuals exhibit higher rates of AUD symptomology, as this is the point in a 
lifespan where individuals are most likely to experiment and consume excessive 
amounts of alcohol (Trim et al., 2009). Importantly, chronic excessive alcohol 
consumption is the leading determinant in developing an alcohol use disorder 
(American Psychiatric Association, 2013; Saha et al., 2006) Thus, understanding 
neurobiological factors contributing to excessive drinking are critical for the development 
of therapeutic options for alcohol abuse.  
Genetics is another risk factor associated with increased rates of alcoholism. 
Nearly 50% of the risk for alcoholism is influenced by genetics, with family history of 
alcoholism as a major risk factor for developing an alcohol use disorder (Grant, 1998). 
Interestingly, an FDA-approved drug with efficacy for reducing heavy drinking, has 
exhibited limited effectiveness amongst individuals who are alcohol-dependent; as 
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genetic variability is proposed to account for reduced efficacy (Oroszi et al., 2009). 
These data emphasize the value of studies that incorporate some component of genetic 
influence.      
 
Excessive Drinking in Humans: Neurological and Behavioral Maladaptations 
Heavy drinking and alcohol abuse lead to profound deficits in neuronal function 
which regulates behavior, memory, judgment, and various other functions in humans. 
For example, several studies show brain shrinkage and reductions in both white and 
grey matter in the frontal lobes of post-mortem alcoholics (Kril et al., 1997; Kubota et al., 
2001). This ethanol-induced maladaptations is key, as areas of the frontal lobe 
modulate high order cognitive processes such as impulse control, planning, and 
decision making in humans (Andersen and Cui, 2009; Fellows and Farah, 2005; Qiu et 
al., 2013). Indeed, studies indicate that  individuals with a history of excessive ethanol 
consumption self-report increased impulsivity (MacKillop et al., 2007) and exhibit deficits 
in impulse control using various tasks that measure impulsivity (Ahmadi et al., 2013; 
Reed et al., 2012). Furthermore, individuals who suffer from alcohol use disorders often 
report high levels of alcohol craving (Anton et al., 1995); sometimes the result of 
exposure to alcohol-associated cues (Field et al., 2004; Lee et al., 2006). Alcohol 
craving is critically important because it is often associated with increased risk of 
relapse after a period of abstinence (Schneekloth et al., 2012). Naltrexone has recently 
been shown to be effective at reducing alcohol-cue-elicited craving in heavy drinkers 
(Miranda et al., 2013).The effect of naltrexone on craving in heavy drinkers is interesting 
given that excessive alcohol induces maladaptations in brain development that mediate 
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craving and impulsivity, two possibly related phenomena (Joos et al., 2013). Although 
there is substantial evidence that excessive drinking can cause neuronal deficits and 
dysfunctional behavior in humans, the underlying molecular mechanisms are difficult to 
determine as investigators are limited in the scope of studies that can be conducted in 
human subjects. 
 
Value of Preclinical Animal Drinking Models 
Animal drinking studies are extremely valuable because behavioral pathologies 
of alcoholism can be modeled while offering in-depth insights into underlying neuronal 
mechanisms. A vast amount of information has been gained from the use of animal 
models to study various aspects of alcohol consumption, including the development of 
pharmacotherapies for the treatment of alcohol use disorders (McKinney, 2001). Animal 
drinking studies provide investigators with a great deal of control over various 
experimental variables that might affect drinking including an animal’s drinking history, 
genetic background, access to alcohol, and environmental stimuli. It is important to note 
that in some cases, voluntarily consumed drugs can produce distinct neuroadaptations 
as compared to investigator-administered drugs (Jacobs et al., 2005). This evidence 
suggest a divergence of neuroadaptations caused by pharmacological actions of drugs 
and neuroadaptations related to voluntary drug use (Wise, 2000), and further provides 
an incentive to study functional implications of ethanol-induced neuroadaptations that  
modulate drinking behavior.  
Accordingly, in this dissertation the focus is primarily on neuroadaptations and 
alterations in patterns of behavior related to voluntary ethanol consumption as our goal 
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is to identify neuronal substrates that alter drinking. Our efforts are primarily centered on 
measurements of ethanol reinforcement and relapse-like behavior as both are easily 
modeled in animals (Cannady et al., 2013; Hodge et al., 1993a; Hodge et al., 2006; 
Hodge et al., 1992; Schroeder et al., 2008) and implicated in various aspects of alcohol 
abuse disorders. Several species are used in studies that examine aspects alcohol 
abuse including rats, mice, hamsters, monkeys, and drosophila, among others 
(Cannady et al., 2013; Chen et al., 2010; Ferris, 2003; Grant et al., 2000; Hodge et al., 
2006). Each species presents its own set of advantages and challenges when 
conducting drinking studies. Given the scope of this dissertation, we will focus primarily 
on rodent models of alcohol consumption. 
 
Rodent Alcohol Drinking Models 
Rodent models are very practical for studying multiple aspects of alcohol 
drinking. An incredible amount of literature exists on their behaviors, physiological 
makeup, and genetic backgrounds. Additionally, rodents can be trained to complete 
complex tasks that mimic behavioral processes observed in humans, such as working 
for an ethanol solution, or seeking ethanol after stress or exposure to alcohol-related 
stimuli (Cannady et al., 2013; Hodge et al., 1993b; Sidhpura et al., 2010). One 
challenge of using rodents in drinking studies is that most rodents do not readily 
consume pharmacologically relevant amounts of alcohol. In this case, the term 
“pharmacologically relevant” refers to the ability for a drug, such as alcohol, to travel 
throughout the body and exert its actions at its target sites; ultimately producing 
detectable changes in behavior or physiological processes (Lange and Dietrich, 2002; 
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Levy, 1986). Over the years investigators have adopted several methods to surmount 
the challenge of inducing relevant drinking levels in rodents including: forced exposure, 
fluid and/or food restriction, ethanol-containing liquid diet, gradually increasing ethanol 
concentrations, and masking/altering the flavor of alcohol with highly palatable additives 
(i.e. sucrose, and saccharin) (Falk et al., 1972; Knapp et al., 1998; Lieber and Decarli, 
1976; Tolliver et al., 1988). Additionally, multiple rodent lines have been established 
using selective breeding procedures that result in rodent strains with a high (or low) 
preference for ethanol. Typically, it takes minimal effort of investigators to induce and 
maintain pharmacologically relevant drinking levels in selectively bred lines as opposed 
to outbred strains (McMillen et al., 1998); making selectively bred strains a valuable 
asset for drinking studies (Bell et al., 2006a; Crabbe et al., 2010).  Given that family 
history is a major factor that influences excessive drinking and alcohol use disorders, 
selectively bred lines also allow for the opportunity to examine genetic contributions to 
drinking. 
In most instances, selective breeding is achieved by examining preference for 
alcohol (vs water) using a two-bottle choice procedure where high preference mating 
pairs produce offspring that are subjected to the same selective breeding process for 
multiple generations. The culmination of continuous mating of high- (or low-) alcohol 
preferring offspring results in the  production of selectively bred strains with similar 
genetic and behavioral phenotypes (Crabbe, 2008). Some common features of 
selectively bred rodent drinking lines include dysregulation of serotinergic signaling 
systems in limbic brain regions, development of rapid tolerance, and disposition to 
voluntary consume ethanol until they reach significantly elevated blood alcohol levels 
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(Crabbe, 2008; Crabbe et al., 2010). There are several selectively bred rat and mouse 
lines; however, this dissertation will focus primarily on alcohol preferring (P-) rats as 
data was collected using this selectively bred strain in all of the studies included in this 
dissertation.  
 
Alcohol preferring (P-) rats 
Alcohol-preferring rats (P-rats) were selectively bred at the University of Indiana 
in the 1970s from a heterogeneous stock of Wistar rats using bidirectional selection 
procedures. Male and female rats with a high preference for a 10% ethanol solution in a 
two-bottle choice procedure were mated producing high preference offspring; while 
mating pairs with a low preference produced low alcohol-preferring offspring, later called 
alcohol non-preferring rats (NP-rats) (Li et al., 1979; Penn et al., 1978). P-rats are 
prominently used in the alcohol field and provide an excellent model that closely fits 
proposed criteria for a rodent model of alcoholism (Bell et al., 2006a). 
P-rats frequently consume pharmacologically relevant doses of ethanol and can 
voluntarily obtain blood ethanol concentrations up to 200mg% under 24 hour limited 
access conditions (Bell et al., 2006b; Rodd-Henricks et al., 2001). They consistently 
consume more than 5mg/kg of ethanol per day; five times more than NP rats (Li et al., 
1987). P-rats are also able to develop rapid tolerance (Lumeng and Li, 1986) and 
exhibit signs of physical dependence and withdrawal after prolonged free choice 
drinking (Kampov-Polevoy et al., 2000).  
Important for the context of this dissertation, P-rats can be trained in operant 
conditioning procedures to self-administer pharmacologically relevant doses of ethanol 
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solutions (Besheer et al., 2008a; Besheer et al., 2008b; Cannady et al., 2013; Samson, 
1986); even in the presence of other palatable solutions such as sucrose (Samson et 
al., 1998). Moreover, P-rats can model aspects of relapse as evidenced by potentiated 
alcohol responding after alcohol deprivation or extinction of operant responding 
(Cannady et al., 2013; Rodd-Henricks et al., 2001; Schroeder et al., 2008).  
 
Measuring Ethanol Reinforcement 
The concept of reinforcement is fundamental to understanding addictive 
processes as it has been suggested that all drugs of abuse serve as positive reinforcers 
that maintain drug-seeking and taking (Stolerman, 1992). Reinforcement is 
conceptualized as a consequence that follows an operant response that increases the 
likelihood of that response occurring in the future (Skinner, 1965). Indeed, alcohol 
consumption induces pleasurable states in humans and animals that promote or 
“reinforce” subsequent drinking episodes. Operant conditioning procedures are ideal for 
measuring complex behavioral processes such as alcohol reinforcement and provide 
investigators with quantitative indices of the reinforcing properties of alcohol (an 
appetitive measurement) while also offering the ability to measure consumatory 
behavior (Samson, 1996). These procedures are often preferred over traditional 
drinking studies, such as two-bottle choice procedures which lack precise behavioral-
temporal resolution and provide limited information about alcohol reinforcement and 
motivational properties.    
In operant alcohol self-administration procedures, access to alcohol is contingent 
on a conditioned response (typically responding on a lever). The response requirement 
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or schedule of reinforcement for an animal may be manipulated to examine various 
aspects of behavior. For instance, animals responding on a fixed-ratio schedule of 
reinforcement provide an index of the reinforcing properties of ethanol. In efforts to 
examine motivation to work for alcohol, an animal may be tested on a progressive ratio 
schedule of reinforcement where response contingency increases after successfully 
obtaining each alcohol reinforcer (Besheer et al., 2008b).  
 
Modeling Relapse to Ethanol-Seeking 
Alcoholism is characterized by cycles of heavy drinking periods interspersed with 
attempts to remain abstinent and the subsequent relapse episodes (McLellan et al., 
2000). Relapse remains one of the major obstacles for clinicians seeking to treat 
alcoholic patients. Despite lengthy periods of abstinence, individuals that abuse alcohol 
remain vulnerable to relapse for the duration of their lives (Vaillant, 1996). Animal 
models are valuable in that multiple facets of relapse can be replicated in a relatively 
short amount of time (Martin-Fardon and Weiss, 2013).  
Often, reinstatement procedures are used to model relapse-like episodes in 
animal models. The three factors that contribute most to alcohol relapse susceptibility 
are environmental stimuli (or cues), stress, and exposure to alcohol during abstinence 
(also known as priming) (Martin-Fardon and Weiss, 2013). Cue-induced reinstatement 
procedures mimic relapse episodes triggered by environmental stimuli (Koob, 2000). 
During a reinstatement procedure, a cue that had previously been paired with alcohol 
delivery is presented. Cues are often reintroduced in the absence (or sometimes 
presence) of alcohol allowing for reinstatement of previous alcohol-seeking behavior. 
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Animals typically exhibit significantly increased alcohol-seeking (e.g. lever responding) 
relative to extinction conditions (Cannady et al., 2013; Schroeder et al., 2008); which 
mimics compulsive alcohol-seeking often observed in humans (Koob, 2000). Stress- 
induced reinstatement sessions differ slightly in that alcohol relapse episodes are 
triggered by stressful events as alcohol-seeking behavior is elicited by exposing animals 
to various stressors (i.e. restraint or footshock) (Zhao et al., 2006). Priming-induced 
reinstatement sessions model alcohol relapse episodes as alcohol-seeking behavior is 
triggered by exposure to alcohol (Le and Shaham, 2002).  In all three reinstatement 
procedures, alcohol-seeking behavior is tightly controlled by the three respective factors 
that contribute to relapse in humans and thus engenders considerable face validity for 
these procedures.   
 
The Actions of Alcohol in the Central Nervous System 
Alcohol or (Ethanol; C2H5OH) is small lipid and water soluble molecule that can 
easily enter the bloodstream and penetrate the blood brain barrier; acting as a central 
nervous system (CNS) depressant. Alcohol has actions at multiple neuronal targets 
which allows for a wide array of effects and has been shown to directly interact with 
several neurotransmitter receptors (Squire, 2008).  
 
GABA Receptors 
Alcohol potentiates neurotransmission at inhibitory gamma-aminobutyric acid 
(GABA) receptors with increased sensitivity to those receptors containing the GABAA 
subunit (Wallner et al., 2003). Activation of GABA receptors is associated with sedation 
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(Boehm et al., 2006) and altered sensitivity to the subjective effects of alcohol (Hodge 
and Aiken, 1996; Hodge and Cox, 1998). It has been suggested that prolonged 
exposure to alcohol downregulates GABA-mediated signaling to promote a 
hyperexcited state which has been linked to dependence and withdrawal in humans 
(Golovko et al., 2002).  
 
Serotonin Receptors 
Alcohol also has actions to potentiate 5-hydroxytryptamine 3 (serotonin) 
receptors (Lovinger, 1999). Many alcohol-preferring rodent lines show deficits in 
serotonin receptor expression which suggest that alcohol interactions at this receptor 
could contribute to behavioral phenotypes observed in these models (Bell et al., 2006a). 
Further, blocking activity at serotonin receptors reduces voluntary consumption (Hodge 
et al., 1993b; Zhou et al., 1998) and relapse like behavior (Rodd-Henricks et al., 2000) 
in rodents, which suggests that this signaling pathway is important in alcohol pathology.  
 
Dopamine Receptors 
Dopaminergic signaling systems have been well-established to modulate drug-
taking and seeking behavior. Therefore it is no surprise that alcohol exerts its effects 
through dopamine receptors. Indeed, low doses of alcohol cause dopaminergic neurons 
in the ventral tegmental area to fire at a high rate (Gessa et al., 1985). Additionally, 
knockout mice with deletions of dopamine receptor subtypes show reduced drinking 
behavior (Crabbe et al., 2006). Administration of dopamine receptor antagonists reduce 
drinking behavior in a variety of animal models (Hodge et al., 1992; Samson et al., 
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1993), but see (Rassnick et al., 1993). While alcohol can have effects on these and 
other neurotransmitters/ neuromodualtors, the focus of this dissertation is on 
glutamatergic neurotransmission and the effects of alcohol to modulate signaling and 
glutamate-mediated behavior. 
 
Glutamate 
Glutamate is the most abundant excitatory neurotransmitter in the CNS. It has 
been suggested that over half of all brain synapses release glutamate (Purves, 2001); 
which makes glutamate an intriguing neuronal substrate for the study of pathological 
function. Indeed, concerted efforts to examine the role of glutamate in alcoholism have 
been employed by many investigators in recent years as dysfunction of glutamate 
signaling has been proposed to be a major contributing factor in addictive disorders 
(Kalivas, 2009). Accordingly, this dissertation focuses on glutamate signaling in 
modulating alcohol drinking behaviors.  
Glutamate is synthesized within neurons from precursor molecules such as 
glutamamine (from glial cells) via conversion by the enzyme, glutaminase, in 
presynaptic terminals. Once glutamate is packaged and released, it binds to glutamate 
receptors and then reuptake occurs which is modulated by high-affinity vesicular 
glutamate transporters (vGluTs) and sodium-dependent excitatory amino acid 
transporters (EAATs) located in glial cells and presynaptic terminals (Purves, 2001; 
Squire, 2008). Upon release, glutamate binds to a diverse set of glutamate receptor 
subtypes.  These glutamate receptors are classified into two major classes: 
metabotropic and ionotropic. Metabotropic glutamate receptors (mGluRs) are G-protein 
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coupled receptors and modulate neuronal activity via slower intracellular signaling 
cascades, whereas ionotropic glutamate receptors are ligand-gated ion channels that 
mediate rapid glutamate neurotransmission (Purves, 2001; Squire, 2008).   
 
Metabotropic Glutamate Receptors  
mGluRs are comprised of three subgroups, Groups I-III. Each group consists of 
multiple mGluR receptor subtypes that are grouped based on pharmacological 
properties, molecular structure, and similar sequence homology (Squire, 2008).  
Group I Receptors: mGluR1 and mGluR5  
Evidence implicates multiple mGluR subtypes in modulating various responses to 
alcohol.  The group 1 mGluRs are comprised of mGluR1 and mGluR5. Group I 
receptors are Gαq- coupled, and activation by glutamate stimulates phospholipase C, 
resulting in phosphoinositol hydrolysis and the formation inositol triphosphate (IP3) and 
diacylglycerol (DAG), which in turn can activate various intracellular messengers (Conn 
and Pin, 1997; Purves, 2001; Squire, 2008). mGluR1 antagonists attenuate ethanol-
induced dopamine and glutamate release (Lominac et al., 2006). Moreover, reduction of 
activity at Group 1 mGluRs has been shown to modulate alcohol-induced sedation 
(Downing et al., 2010), alcohol self-administration (Besheer et al., 2008a; Besheer et 
al., 2008b; Besheer et al., 2010; Gass and Olive, 2009; Hodge et al., 2006) and relapse-
like behavior (Schroeder et al., 2008; Sidhpura et al., 2010), while also modulating the 
subjective effects of ethanol (Besheer et al., 2009; Besheer and Hodge, 2005).   
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Group II Receptors: mGluR2 and mGluR3 
Group Group II mGluRs are comprised of mGluR2 and mGluR3. These Gi-
coupled receptors function as autoreceptors and regulate presynaptic neurotransmitter 
release (Baskys and Malenka, 1991; Farazifard and Wu, 2010; Liu et al., 1993; Macek 
et al., 1996; Molinaro et al., 2009). As such, activation of mGlu2/3 receptors decreases 
the synaptic availability of glutamate, which allows for ‘refinement' of glutamatergic 
neurotransmission (Pinheiro and Mulle, 2008; Schoepp, 2001). Group II receptors have 
been shown to modulate relapse-like to alcohol-seeking behavior (Sidhpura et al., 2010; 
Zhao et al., 2006) and the subjective or discriminative stimulus effects of alcohol 
(Cannady et al., 2012). 
Group III Receptors: mGluR4 and mGluR6-8 
Group III receptors include mGluR4 and mGluR6-8 subtypes, and similar to 
Group II recptors, are Gi-coupled and function to regulate glutamate release (Conn and 
Pin, 1997; Purves, 2001; Squire, 2008).  These receptors have been studied the least or 
the mGluR family, but evidence suggest a role for mGluR7 and mGluR8 in modulating 
alcohol reinforcement (Backstrom and Hyytia, 2005; Salling et al., 2008).   
 
Ionotropic Glutamate Receptors 
NMDA Receptors 
Of the glutamate receptor subtypes, N-methyl-D-aspartate (NMDA) receptors 
have been the most widely studied in relation to alcohol use disorders. NMDA receptors 
are comprised of four subunits (GluN1-4) and when activated by glutamate and glycine 
(co-agonist), these receptors allow for influx of cations such as calcium (Ca2+) sodium 
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(Na+) and potasium (K+) ions (Squire, 2008). These receptors are well known for their 
role in modulating plasticity related events, including LTP, a cellular correlate of learning 
and memory (Malinow et al., 1989; Purves, 2001; Squire, 2008). Interestingly, acute 
alcohol has a high affinity for NMDA receptors and inhibits activity at these receptors 
(with increased sensitivity at GluN2 containing receptors) (Lovinger et al., 1989). 
Studies show that chronic ethanol upregulates the expression of these receptors 
(Trevisan et al., 1994); likely as a compensatory mechanism for reduced activity through 
inhibition by ethanol. Moreover NMDA antagonists reduce ethanol self-administration 
(Rassnick et al., 1992), as well as produce ethanol-like subjective effects (Grant and 
Colombo, 1993; Hodge and Cox, 1998).    
Kainate Receptors  
Considerably less is known about Kainate receptors due to a shortage of 
selective biochemical and pharmacological tools.  These receptors are ion 
heterotetrameric channel receptors consisting of four of five total subunits named, 
GluK1-5. Kainate receptors are thought to act more as modulators, rather than 
mediators of excitatory neurotransmission as they have significantly slower kinetic 
properties than NMDA and AMPA receptors, and are not as concentrated at excitatory 
post-synaptic sites (Squire, 2008). Further these receptors have a unique ability to 
function as traditional ion channels as well as couple to metabotropic signaling 
pathways (Contractor et al., 2011). In relation to alcohol, very few studies have 
examined the contributions of these receptors. Ethanol does inhibit activity of these 
receptors, and in many cases at very low doses; which suggest that these receptors 
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may play a role in actions of lower concentrations of ethanol (Moykkynen and Korpi, 
2012).       
AMPA Receptors 
Unlike NMDA receptors, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) receptors have received considerably less attention in the alcohol addiction 
field. AMPA receptors are comprised of four subunits (GluA 1-4) and are 
heterotetrameric ligand-gated ion channels that mediate rapid glutamatergic 
neurotransmission. When activated by glutamate, ions such as Na2+ (and Ca2+) are 
allowed to pass through the channel pore and mediate rapid excitatory signaling 
(Squire, 2008). AMPA receptors are important as they play a major role neuronal 
excitation and synaptic plasticity. Specifically, trafficking and incorporation of AMPA 
receptors into synapses is associated with potentiation of synaptic strength; while 
removal results in weakening of synaptic strength (Bredt and Nicoll, 2003; Kessels and 
Malinow, 2009). Indeed potentiation of synaptic strength via AMPA receptor trafficking 
facilitates various processes including learning and memory (Lee et al., 2003). The 
process by which AMPA receptors are incorporated in the synapse is regulated by 
subunit composition (Shi et al., 2001). Several studies indicate that the GluA1 subunit is 
important in facilitating trafficking of AMPA receptors to synaptic sites in an activity-
dependent manner (Larsson and Broman, 2008; Zhu et al., 2000). Furthermore, 
intracellular signaling molecules such as Ca2+ /calmodulin-dependent protein kinase II 
(CaMKII) function as modulators of membrane trafficking by phosphorylating sites on 
the GluA1 subunit (Malinow et al., 1989; Poncer et al., 2002); which allows for dynamic 
variations in AMPA receptor signaling.  
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Rationale 
The actions of ethanol to influence AMPA receptor signaling have not been fully 
determined. At high concentrations, acute ethanol attenuates AMPA receptor signaling 
(Dildy-Mayfield and Harris, 1992; Moykkynen et al., 2003). However, several studies 
show that AMPA receptor subunits are upregulated after long-term ethanol exposure; 
possibly due to a compensatory mechanism. Indeed, GluA1 subunit expression is 
upregulated in the nucleus accumbens (Ary et al., 2012; Neasta et al., 2010); a limbic-
motor interface that mediates goal-directed and the reinforcing properties of abused 
drugs (Salamone et al., 2007). Furthermore, studies show that chronic ethanol 
potentiates synaptic strength as evidenced by increases in AMPA/NMDA ratio in brain 
regions that mediate reinforcement (Heikkinen et al., 2009; Stuber et al., 2008); which 
indicates that ethanol could be altering reinforcement processes by strengthening 
synaptic activity through an AMPA receptor-dependent mechanism. Indeed, 
administration of AMPA receptor antagonists reduce ethanol self-administration 
(Stephens and Brown, 1999; Wang et al., 2012), but it is not known if drinking behavior 
can be augmented by enhancing activity at AMPA receptors. GluA1 is also upregulated 
in the amygdala after chronic ethanol (Christian et al., 2012); a region well-
characterized in mediating intense emotional states and associative learning processes 
(LeDoux, 2003) including drug-reward learning (Aston-Jones and Harris, 2004; Koob et 
al., 1998). This region has been implicated in modulating ethanol reinforcement and 
relapse-like behavior (Schroeder et al., 2003; Schroeder et al., 2008). Interestingly, 
antagonism of AMPA receptor signaling has been shown to reduce relapse to ethanol-
seeking behavior in reinstatement procedures (Backstrom and Hyytia, 2004; Sanchis-
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Segura et al., 2006).  It is not clear, however, as to how enhanced AMPA receptor 
activity could modulate ethanol reinforcement or seeking behavior.  
Therefore, the overall goal of this project is to determine how enhanced AMPA 
receptor activity might exacerbate ethanol reinforcement and relapse-like behavior 
using a preclinical model of high ethanol intake; the alcohol-preferring (P-)rat. The 
following three Specific Aims tested the hypothesis that enhanced activity at AMPA 
receptors in specific limbic brain regions facilitates ethanol reinforcement and promotes 
relapse to alcohol-seeking.  
 
Specific Aim 1:  
Examination of pharmacological enhancement of AMPA receptor activity to modulate 
alcohol self-administration and relapse-like behavior. The mechanistic role of enhanced 
AMPA receptor activity in alcohol-reinforcement and alcohol-seeking had not been 
previously determined. Therefore, we examined the role of enhanced AMPA receptor 
function using the selective positive allosteric modulator, aniracetam, in modulating 
operant alcohol self-administration and cue-induced reinstatement. Male alcohol-
preferring (P-) rats trained to self-administer alcohol versus water were pre-treated with 
aniracetam to assess effects on maintenance of alcohol self-administration. Locomotor 
assessments were conducted following aniracetam treatment to assess if changes in 
alcohol self-administration were associated with non-specific motor effects. The effects 
of aniracetam on alcohol clearance were tested to rule out possible alterations in 
alcohol clearance. To determine reinforcer specificity, P-rats were trained to self-
administer sucrose versus water, and effects of aniracetam were tested. The role of 
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aniracetam in modulating relapse of alcohol-seeking was assessed using a response 
contingent cue-induced reinstatement procedure in alcohol self-administering P-rats.  
Specific Aim 2:  
Investigation of brain regional involvement of enhanced AMPA receptor activity to 
modulate excessive alcohol self-administration. Aim 1 data showed that enhanced 
activity at AMPA receptor receptor by systemic aniracetam increased alcohol self-
administration in a rodent model of high alcohol intake, the alcohol-preferring (P-) rat. 
Experiments in this Aim extended findings in Aim 1 by examining neuroanatomical 
substrates and the behavioral and molecular mechanisms underlying enhanced AMPA 
receptor-mediated increases in alcohol self-administration.  First, using 
immunohistochemistry (IHC) we examined pGluR1831 immunoreactivity in limbic brain 
regions of P-rats trained to self-administer alcohol or sucrose. We focused on the 
amygdala and nucleus accumbens given their roles in modulating alcohol drinking 
behaviors. Next, guided by the IHC results, we conducted functional studies to 
determine neuroanatomical control of enhanced AMPA receptor activity in modulating 
increased alcohol self-administration. Control experiments assessed anatomical and 
reinforcer specificity and evaluated non-specific changes in locomotor behavior. Finally, 
we determined if aniracetam-induced increases in alcohol self-administration are 
dependent on CaMKII activity using a CaMKII peptide inhibitor (myristolated AIP).   
Specific Aim 3:  
Investigation of brain regional involvement of enhanced glutamate signaling at 
AMPA receptors in modulating relapse-like behavior. Data from Aim 1 showed that 
reinstatement to alcohol seeking is potentiated by systemic aniracetam after exposure 
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to previously-paired alcohol-associated cues. Therefore, experiments in this Aim 
examined the role of enhanced AMPA receptor-mediated relapse-like behavior in P-
rats. First, using western blot analysis, we evaluated changes in pGluA1 in limbic brain 
regions in response to exposure to alcohol-paired cues during a cue-induced 
reinstatement test in alcohol self-administering P-rats. We predicted changes in the 
amygdala given its role in modulating cue-reward associations. Next, we tested the 
functionality of AMPA receptor in the amygdala by site-specific pharmacological 
enhancement of AMPA receptor activity prior to reinstatement sessions. 
Collectively, these studies provide insights into novel mechanisms for excessive 
drinking behavior and relapse to alcohol seeking; two prominent features of alcohol use 
disorders. 
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CHAPTER 2: ENHANCED AMPA RECEPTOR ACTIVITY INCREASES OPERANT 
ALCOHOL SELF-ADMINISTRATION AND CUE-INDUCED REINSTATEMENT1  
 
Introduction 
Glutamate signaling has been widely implicated in modulating addiction to 
alcohol (ethanol) and other drugs of abuse (Gass and Olive, 2008; Kalivas, 2009). The 
role of N-Methyl-D-aspartic acid (NMDA) receptors and metabotropic glutamate 
receptors in ethanol reinforcement processes and relapse have been studied 
extensively (Backstrom and Hyytia, 2004; Besheer et al., 2010; Bienkowski et al., 1999; 
Schroeder et al., 2008); however, the functional role of α-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate (AMPA) receptors in these behaviors has received less attention. 
AMPA receptors are a subclass of ionotropic glutamate receptors that are ubiquitously 
expressed throughout the brain (Petralia and Wenthold, 1992). These receptors 
mediate fast excitatory glutamate neurotransmission and play a key modulatory role in 
major neural functions and processes, including synaptic plasticity (Kessels and 
Malinow, 2009). This is significant given that chronic exposure to drugs of abuse is 
associated with molecular maladaptations that influence synaptic plasticity events within 
brain reward circuitry (Kalivas, 2009; Nestler and Aghajanian, 1997). Interestingly, 
AMPA receptors have been implicated in modulating the addictive properties of a 
                                            
1 Previously published chapter: Cannady, R., Fisher, K.R., Durant, B.A., Besheer, J., 
Hodge, C.W. (2013) Enhanced AMPA receptor activity increases operant alcohol self‐administration and 
cue‐induced reinstatement. Addiction Biology, Jan;18(1):54‐65. PMID: 23126443 
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variety of drugs of abuse (Bowers et al., 2010; Choi et al., 2011; Van den Oever et al., 
2008). Thus, a better understanding of how activity at AMPA receptors might influence 
drug-taking and seeking behaviors may provide novel insights into the etiology of the 
multiple phases of drug addiction. 
Emerging evidence suggests that investigator-administered ethanol and chronic 
ethanol consumption influences AMPA receptor trafficking to excitatory synapses. 
Studies show that a history of ethanol exposure upregulates AMPA receptor subunit 
proteins in rodents (Ary et al., 2012; Chandler et al., 1999; Neasta et al., 2010) and in 
post-mortem brain preparations of human alcoholics (Breese et al., 1995). Moreover, 
these ethanol -induced neuroadaptations have been implicated in the strengthening of 
synapses within limbic brain regions that mediate reward, as evidenced by increases in 
the ratio of AMPA receptor- to NMDA receptor-mediated currents (AMPA/NMDA ratio); 
suggesting a role for AMPA receptor-dependent enhanced synaptic function in ethanol 
drinking behavior (Ary et al., 2012). For example, both investigator-administered ethanol 
(Heikkinen et al., 2009; Saal et al., 2003) as well as voluntary ethanol consumption 
(Stuber et al., 2008) have been shown to increase AMPA/NMDA ratio in the ventral 
tegmental area, a region well characterized for it’s role in mediating  the reinforcing 
properties of drugs of abuse and relapse-like behavior (Hodge et al., 1993a). Indeed, 
administration of AMPA receptor antagonists have been shown to reduce alcohol self-
administration (Stephens and Brown, 1999), and block reinstatement of alcohol-seeking 
in rats (Backstrom and Hyytia, 2004) and mice (Sanchis-Segura et al., 2006). 
Collectively, these studies demonstrate that AMPA receptor signaling is required for the 
expression of the reinforcing effects of ethanol and is important in modulating relapse-
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like behavior. However, it remains unclear how enhanced activity at AMPA receptors 
can influence ethanol -reinforcement processes and ethanol -seeking behavior. 
Thus, the goal of the present study was to determine the effect of acute 
potentiation of glutamate activity at AMPA receptors on operant ethanol self-
administration and cue-induced reinstatement of alcohol-seeking behavior using the 
positive allosteric modulator, aniracetam (Isaacson and Nicoll, 1991). To address this 
question, we used a genetic inbred model of high ethanol intake; the alcohol-preferring 
(P-) rat (Lankford et al., 1991; Murphy et al., 1989). Accordingly, P-rats were trained to 
self-administer ethanol (15%, v/v) vs. water using a well-characterized 2-lever operant 
self-administration procedure. The effects of aniracetam were evaluated on the 
maintenance of ethanol self-administration. Locomotor assessments were conducted 
following aniracetam treatment to assess if changes in ethanol self-administration were 
associated with nonspecific motor effects. The effects of aniracetam on ethanol 
clearance were tested to rule out possible alterations in ethanol clearance. To confirm 
AMPA receptor specificity in the modulation of ethanol self-administration, the AMPA 
receptor antagonist 6,7-Dinitroquinoxaline-2,3-dione (DNQX), was administered prior to 
aniracetam pretreatment. Further, to determine reinforcer specificity, aniracetam was 
tested in P-rats trained to self-administer sucrose (0.8%, w/v) prior to self-administration 
sessions. Finally, the effects of aniracetam on relapse-like behavior were assessed 
using a response-contingent cue-induced reinstatement procedure. 
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Materials and Methods 
Animals  
Adult male inbred alcohol-preferring (P-) rats (400 - 500 g prior to testing) were 
bred in-house. P-rats were derived from a line provided by Indiana University. This 
stock of inbred P-rats (5B substrain) was derived from breeders of the selected line of 
P-rats originally provided in 1999 by Indiana University (courtesy of Dr. T.K. Li) and has 
been bred on-site at the University of North Carolina at Chapel Hill. Animals were pair-
housed in Plexiglas cages and handled daily prior to any training procedures.  All rats 
had access to food and water ad libitum in the homecage between test sessions (unless 
mentioned otherwise). The colony room was maintained on a 12 hour light/dark cycle 
(lights on at 7am) and experiments were conducted approximately 3 hrs into the light 
portion of the cycle. All procedures used were conducted in accordance with the 
National Institute of Health guidelines, and approved by the University of North Carolina 
Institutional Animal Care and Use Committee.  
 
Apparatus 
Self-administration Chambers. Operant conditioning chambers measuring 30.5 x 
24.1 x 21.0 cm (Med Associates, Georgia, VT) were located within sound-attenuating 
cubicles. Each cubicle was equipped with an exhaust fan for ventilation which also 
functioned to mask external sounds. The left and right wall of each chamber contained a 
liquid receptacle in addition to a response lever (i.e. two levers per chamber). Lever 
press responses activated a syringe pump (Med Associates) that delivered 0.1 ml of 
solution into the receptacle over 1.66 seconds. A stimulus light located above each 
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response lever was simultaneously illuminated during pump activation. Lever responses 
during reinforcer delivery were recorded, but did not produce programmed 
consequences. The chambers were interfaced (Med Associates) to a computer 
programmed to control sessions and record data.  
Locomotor Chambers.  Clear Plexiglas chambers (43.2 cm x 43.2 cm; Med 
Associates) were used to assess locomotor activity. Horizontal distance traveled (cm) 
was determined from the number of photobeam breaks and collected via computer 
interface  in 2 min time intervals using Activity Monitor locomotor activity software (Med 
Associates).  
 
Operant Self-administration  
Training. One day prior to training, rats were fluid-restricted for approximately 24 
hrs. Immediately afterwards, rats were placed in the operant conditioning chambers for 
an initial 16-hr lever-press training session in which presentation of a 0.1 ml solution of 
concurrently available sucrose (10 %, w/v) and water was contingent on lever 
responses. Lever responses were initially maintained on a concurrent fixed-ratio 1 
(CONC FR1 FR1) schedule of reinforcement and were gradually increased to CONC 
FR2 FR2 after delivery of 4 reinforcers, and then further increased to CONC FR4 FR4 
after delivery of 10 reinforcers. All reinforcer deliveries were paired with an illumination 
of a light cue located above each response lever. After completing the initial 16 hr 
training session, rats were returned to their homecage for a period of 24 hrs in which 
access to water was returned and remained available ad libitum thereafter.  
27 
 
Sucrose Fading and Baseline Sessions. Next, rats commenced daily (Monday–
Friday) 30-min sessions (CONC FR4 FR4) where the sucrose concentration was 
gradually decreased and the ethanol concentration was increased using a modified 
sucrose-fading procedure (Samson, 1986) as previously described (Besheer et al., 
2010; Hodge et al., 1993b). Briefly, ethanol was gradually added to the 10% (w/v) 
sucrose solution and sucrose was gradually faded out so that ethanol (15%, v/v) alone 
maintained lever pressing. The exact order of mixed ethanol exposure was as follows: 
10% sucrose/2% alcohol (10S/2E), 10S/5E, 10S/10E, 5S/10E, 5S/15E, 2S/15E, 
0S/15E. There were 2 sessions at each concentration (i.e., 12 total sucrose fading 
sessions). Sucrose-trained P-rats did not receive ethanol and were faded to 0.8% (w/v) 
sucrose. The exact order of sucrose fading was as follows: 10S, 5S, 2S, 1S, 0.8S, 0.4S. 
The final sucrose concentration was readjusted to 0.8% (w/v) sucrose because this 
concentration produced similar lever responding as compared to the 15% alcohol-
trained animals. After the sucrose fading procedure, rats had a minimum of 28 baseline 
operant self-administration sessions with 15% ethanol vs. water (alcohol-trained P-rats) 
or 0.8% sucrose vs. water (sucrose-trained P-rats).  
 
Examination of positive modulation of glutamate activity at AMPA receptors on 
ethanol self-administration.  
To test whether potentiation of AMPA receptor signaling might influence ethanol 
reinforcement processes, P-rats (n = 9) were pretreated with aniracetam (0, 1, 5, 10, 30 
mg/kg, i.p.) 30 minutes prior to operant ethanol (15% v/v) self-administration sessions 
(30-min). Aniracetam doses within this range have been shown to be effective at 
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altering behavior in previous studies (Knapp et al., 2002; Lebrun et al., 2000). Testing 
was conducted using a within-subjects design in which each aniracetam dose was 
administered in a randomized order. As such, BEC measurements were not conducted 
after each drug test session as blood sampling has the potential to disrupt ongoing self-
administration behavior. There were at least 2 self-administration sessions between 
injections and test sessions occurred no more than two times per week. Additionally, 
each liquid receptacle in the operant chambers was monitored for residual fluid after 
every session.  
 
Test for aniracetam-induced alterations in locomotor behavior.  
Two weeks following aniracetam testing, the P-rats were tested to examine if 
potentiated aniracetam-induced alcohol self-administration was the result of changes in 
locomotor activity. Animals received aniracetam pretreatment (0 and 5 mg/kg, i.p.) 30 
minutes prior to placement in locomotor chambers where distance traveled was 
measured and recorded via photo beam breaks. Each rat experienced two 30-minute 
locomotor sessions in which aniracetam dose order (0 and 5 mg/kg) was randomized. 
Locomotor sessions were interspersed with self-administration sessions where 
appropriate with at least 3 days between tests. Self-administration sessions were 
withheld on days of the locomotor tests. 
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Confirmation of AMPA receptor involvement in modulating increased alcohol self-
administration.  
The AMPA receptor antagonist, DNQX (0 and 3 mg/kg, i.p) was administered 
immediately before aniracetam (0 and 5 mg/kg) to confirm the role of AMPA receptors in 
potentiating ethanol self-administration induced by aniracetam. This dose of DNQX (3 
mg/kg) was chosen because it was the highest dose that did not alter operant ethanol 
self-administration when administered alone in a separate preliminary study (data not 
shown). On test days, each subject received each possible combination of both DNQX 
(0 and 3 mg/kg, i.p) immediately followed by aniracetam (0 and 5 mg/kg, i.p.) in 
randomized order 30 minutes before testing, such that the entire dose-response curve 
was generated over the course of 4 test sessions. 
 
Test for aniracetam-induced alterations in ethanol pharmacokinetics. 
To determine whether aniracetam pretreatment altered ethanol clearance, 
another cohort of P-rats (n=6/ treatment group) with a history of ethanol self-
administration were pretreated with aniracetam (0; or 5 mg/kg; i.p.) 30 minutes prior to 
orally administered ethanol (1 g/kg, IG) and tail blood was collected 20, 30, 60, 120 and 
240 min later. Plasma supernatant (5 µl) was analyzed for ethanol content using an 
Analox Alcohol Analyser (Model AM1, Analox Instruments USA Inc.,Lunenburg,MA). 
 
Test for reinforcer specificity via sucrose-self-administration. 
To test if enhanced AMPA receptor activity was selective at modulating ethanol 
reinforcement, behavior-matched sucrose-trained P-rats (n = 11) were pretreated with 
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aniracetam (0, 1, 5, 10, 30 mg/kg, i.p.) 30 minutes prior to operant sucrose (0.8%, w/v) 
self-administration sessions (30-min). Aniracetam testing was conducted as described 
for the ethanol self-administration tests sessions.  
 
Examination of positive modulation of glutamate activity at AMPA receptors on 
regulating response-contingent cue-induced reinstatement. 
To test the effects of aniracetam on ethanol seeking behavior after exposure to 
an ethanol-associated cue, self-administration-trained P-rats (15% ethanol vs. water; 
CONC FR4 FR4) had a minimum of 28 days of baseline self-administration sessions 
(see above for training procedures). After stable baseline responding, rats underwent 
extinction sessions (30 min) in which previously reinforced responses were extinguished 
over 13 consecutive days by removing response contingencies (i.e. no light cue or 
pump sound; no reinforcers delivered). Treatment groups were matched based on 
baseline response totals and extinction performance. On day 14, ethanol-trained P-rats 
were injected with vehicle (n=8) or aniracetam (5 mg/kg, i.p.; n=7) 30 minutes prior to a 
reinstatement session. During this session (30 min), lever responses (FR4) resulted in 
the presentation of the light cue and pump activation; however, no reinforcers (ethanol 
or water) were delivered. Note: 0.1 ml of the 15% ethanol (v/v) solution was added to 
the ethanol well prior to the reinstatement session. This amount of ethanol (0.1ml) is not 
pharmacologically relevant and functioned to provide additional olfactory/taste cues to 
maximize lever responses during reinstatement (Backstrom et al., 2004).  
To test the effects of aniracetam on extinction responding, the same animals 
were reintroduced to ethanol 15% (v/v) for 10 baseline self-administration sessions.  
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Rats then underwent 12 daily extinction sessions (30 min; see above) and on the 13th 
extinction session, animals were pretreated with vehicle (n=7) or aniracetam (n=7). 
Because aniracetam did not alter sucrose self-administration (see below), the role of 
aniracetam in sucrose reinstatement was not tested in this study. 
Drugs.  
Alcohol (95% (w/v); Pharmco-AAPER, Shelbyville, KY) was diluted in distilled 
water to 15% (v/v). Aniracetam (Tocris, Ellisville, Missouri) was suspended in 0.5% 
Carboxymethyl cellulose (vehicle; Sigma Aldrich, St. Louis, Missouri) and sonicated for 
approximately 15-20 minutes prior to injections. Aniracetam was injected at a volume of 
2 ml/kg (i.p.). DNQX (Tocris, Ellisville, Missouri) was diluted in filtered water and 
injected at a volume of 1 ml/kg (i.p.). 
 
Data Analysis 
Alcohol- (or sucrose-) and water-reinforced responses, cumulative responses, 
and cumulative distance traveled (cm) were analyzed by two-way repeated measures 
analysis of variance (RM ANOVA). Intake (g/kg) were analyzed by one-way RM ANOVA 
and calculated based on rat body weight and number of reinforcers delivered. 
Responding was “extinguished” when ethanol-lever responses were not statistically 
different than water-lever responses for at least two consecutive days (two-way 
ANOVA). Lever responses in the reinstatement session were analyzed by two-way RM 
ANOVA. Tukey post-hoc comparisons were performed to identify differences between 
treatments/treatment groups.  Significance was determined at p ≤ 0.05. Baseline data 
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(mean ± S.E.M.) for the day preceding initial testing of aniracetam is reported in Table 
1. 
 
Results 
Examination of positive modulation of glutamate activity at AMPA receptors on 
ethanol self-administration. 
P-rats trained to self-administer ethanol or water (CONC FR4 FR4) were 
pretreated with aniracetam (0, 1, 5, 10, 30 mg/kg) 30 minutes prior to self-administration 
sessions. Statistical analysis by two-way repeated measures analysis of variance (RM-
ANOVA) indicated significant main effects of reinforcer (F(1,8)=291.82, p<0.001), 
aniracetam dose (F(4,32)=6.77, p<0.001), and a significant interaction of reinforcer x 
aniracetam dose (F(4,32)=6.49, p<0.001). Tukey post-hoc comparisons showed that 
pretreatment with aniracetam (1 and 5 mg/kg) resulted in a significant increase in 
ethanol-reinforced responses vs. vehicle pretreatment (p<0.001), while water-reinforced 
responses were not altered by aniracetam pretreatment (Figure 1A). The mean values 
(± SEM) for ethanol intake (g/kg) during self-administration after pretreatment with each 
aniracetam dose were as follows:  0.71 ± 0.08 (vehicle), 0.90 ± 0.1 (1 mg/kg), 1.14 ± 
0.07 (5 mg/kg), 0.84 ± 0.09 (10 mg/kg), and 0.86 ± 0.06 (30 mg/kg). One-way RM 
ANOVA showed a significant increase in ethanol intake (F(4,32)=5.64, p=0.001) after 
aniracetam pretreatment, with over a 60% increase in consumption (5 mg/kg 
aniracetam vs. vehicle treatment, P<0.05). Furthermore, statistical analysis of the rate of 
ethanol lever responding over time (cumulative lever responses) by two-way RM 
ANOVA showed significant main effects of time (F(5,40)=47.20, p<0.001), and dose 
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(F(4,32)=4.72, p=0.004), and a significant interaction of time x dose (F(20,160)=4.04, 
p<0.001). Post-hoc analysis indicated that the aniracetam-induced increase in ethanol-
reinforced responses emerged early (by 10 min) and persisted throughout the duration 
of the 30-minute test session (5 mg/kg aniracetam; Figure 1B). Together these data 
suggest that enhanced glutamate activity at AMPA receptors enhances the reinforcing 
effects of ethanol.  
 
Test for aniracetam-induced alterations in locomotor behavior. 
To test for non-specific changes in locomotor behavior that may have influenced 
lever responding during operant ethanol self-administration tests, P-rats were pretreated 
with aniracetam (0 or 5 mg/kg) prior to locomotor assessments in an open field. Two-
way RM ANOVA showed that cumulative distance traveled (cm) increased over time 
(F(14,112)=151.68, p<0.001), and aniracetam pretreatment did not alter this pattern of 
behavior (F(1,8)=0.45, p=0.84; Figure 1C), suggesting that increased ethanol lever 
responses after aniracetam pretreatment were likely not due to non-specific aniracetam-
induced changes in locomotor behavior.  
 
Confirmation of AMPA receptor involvement in modulating increased ethanol 
self-administration.  
Rats received double injections of DNQX and aniracetam to verify the role of 
AMPA receptors in potentiating ethanol-reinforced responses during operant self-
administration sessions. Analysis by two-way RM ANOVA showed a main effect of 
DNQX dose (F(1,8)=15.36, p=0.004), but no main effect of aniracetam dose 
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(F(1,8)=0.15, p=0.71). There was a significant interaction of aniracetam dose x DNQX 
dose (F(1,8)=,18.28, p=0.003). Post-hoc analysis indicated that DNQX (3 mg/kg) was 
ineffective at altering ethanol self-administration when administered in combination with 
vehicle (Aniracetam 0 mg/kg; Figure 2 left panel). Importantly, pretreatment with DNQX 
(3 mg/kg) significantly blocked aniracetam-induced increased ethanol self-
administration (aniracetam 5 mg/kg; Figure 2). Water lever responding was not altered 
by DNQX and aniracetam pretreatment. Two-way ANOVA showed no main effects of 
DNQX dose(F(1,8)=1.82, p=0.21), aniracetam dose(F(1,8)=1.74, p=0.22) and no 
significant interaction of DNQX x aniracetam (F(1,8)=0.03, p=0.86). These data confirm 
the role of AMPA receptors in mediating the aniracetam-induced increases in ethanol-
reinforced responding. 
 
Test for aniracetam-induced alterations in ethanol pharmacokinetics.  
To test if increased ethanol self-administration was the result of treatment-
induced alterations in ethanol clearance, P-rats were challenged with a 1 g/kg (IG) dose 
of ethanol following aniracetam (0 vs. 5 mg/kg; i.p) pretreatment (n=6 per treatment 
group). Pretreatment with aniracetam did not alter blood-ethanol clearance over a 4-hr 
period relative to vehicle-treated P-rats (Figure 3). Analysis by two-way ANOVA 
showed a main effect of time (F(5,48)=38.76, p<0.001), but no effect of dose 
(F(1,48)=2.992, p<0.09) or  interaction of time x dose (F(5,48)=0.891, p=0.49). These 
data suggest that increased ethanol self-administration following aniracetam 
pretreatment was not related to a change in the pharmacokinetics of ethanol (Table 2).  
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Test for reinforcer specificity via sucrose self-administration. 
To evaluate reinforcer specificity, aniracetam (0, 1, 5, 10, 30 mg/kg) was tested 
prior to self-administration sessions in sucrose-trained P-rats. Aniracetam did not alter 
operant sucrose or water self-administration in 30-minute test sessions (Figure 4A). 
Analysis by two-way RM ANOVA showed a significant main effect of lever 
(F(1,10)=31.49, p=0.001), but no aniracetam-induced changes in sucrose self-
administration were observed (F(4,40)=1.02, p=0.41). Moreover, examination of the 
cumulative sucrose responses over time (response rate) did not show any statistical 
differences across treatment doses (Figure 4B). Two-way RM ANOVA showed a main 
effect of time (F(5,50)=20.14, p<0.001), however, there was no main effect of dose 
(F(4,40)=0.88, p=0.49) or significant interaction of time x dose (F(20,200)=0.93, 
p=0.55). These data suggest that enhanced glutamate activity at AMPA receptors 
induced by aniracetam pretreatment selectively potentiates ethanol reinforcement 
processes, but not sucrose reinforcement (e.g. a non-drug reward). 
 
Examination of positive modulation of glutamate activity at AMPA receptors on 
regulating response-contingent cue-induced reinstatement. 
To examine the role of enhanced glutamate activity at AMPA receptors in 
modulating ethanol-seeking behavior in P-rats a response contingent cue induced-
reinstatement procedure was used. Removal of response contingencies extinguished 
ethanol-associated lever responding over a period of 13 consecutive days (Figure 5A). 
Statistical analysis by two-way ANOVA showed a main effect of lever (F(1,364)=324.14, 
p<0.001), extinction session (F(12,364)=29.39, p<0.001), and a significant interaction of 
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lever x extinction session (F(12,364)=25.87, p<0.001). Post-hoc comparisons showed 
significant differences in lever responses on the ethanol and water levers, with the 
exception of the last three extinction sessions (p>0.05), which confirms extinction. 
During reinstatement, both treatment groups (vehicle and aniracetam) displayed 
response-contingent cue-induced reinstatement of ethanol-seeking behavior, as 
evidenced by increased responding on the ethanol-associated lever compared to their 
last extinction session (Figure 5B). Two-way RM ANOVA (with test condition as a 
repeating factor) showed significant main effects of aniracetam dose (F(1,13)=10.74, 
p=0.006) and test condition (F(1,13)=89.74, p<0.001) and a significant interaction of 
aniracetam dose x test condition (F(1,13)=11.16, p=0.005). Interestingly, responding on 
the ethanol-associated lever was potentiated in P-rats after pretreatment with 
aniracetam (5 mg/kg vs. vehicle group) during reinstatement (p≤0.05, Tukey post-hoc). 
Responses on the water lever during reinstatement were not altered by 
aniracetam pretreatment (Figure 5C) as no main effect of dose (F(1,13)=0.12, p=0.74), 
test condition (F(1,13)=1.90, p=0.19), or interaction (F(1,13)=0.02, p=0.88) was evident. 
Moreover, an examination of operant responses during extinction did not reveal any 
differences between the aniracetam-treated and vehicle-treated groups. The mean 
values (± SEM) for lever responding during extinction after pretreatment with 
aniracetam were as follows:  4.286 ± 0.92 (vehicle; ethanol lever), 1.286 ± 0.75 (vehicle; 
water lever), 8.286 ± 3.15 (5 mg/kg; ethanol lever), 1.71 ± 0.36 (5 mg/kg; water lever). 
Analysis by two-way ANOVA (with test condition as a repeating factor) showed no main 
effects of dose (F(1,12)=0.41, p=0.53), test condition (F(1,12)=0.70, p=0.42)  and no 
interaction of dose X test condition (F(1,12)=2.16, p=0.17).  These data suggest that 
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potentiated glutamate activity at AMPA receptors exacerbates cue-induced ethanol-
seeking behavior. 
 
Discussion 
The results of this study demonstrate for the first time that enhanced glutamate 
activity at AMPA receptors exacerbates ethanol self-administration and promotes 
reinstatement of ethanol-seeking behavior. First, systemic AMPA receptor activation by 
aniracetam increased ethanol-reinforced responding in P-rats; an inbred rodent strain 
that is considered to fit many of the criteria for an animal model of alcoholism (Bell et al., 
2006a; Kampov-Polevoy et al., 2000). Additionally, the aniracetam-induced increase in 
ethanol-reinforced responding was absent of effects on spontaneous locomotor 
behavior and was not the result of alterations in ethanol clearance. Moreover, the role of 
AMPA receptors was confirmed because the aniracetam-induced increase in ethanol 
self-administration was blocked by administering the AMPA receptor antagonist, DNQX. 
Selective modulation of the reinforcing effects of ethanol was confirmed as aniracetam 
pretreatment did not alter self-administration of an alternative reinforcer (i.e. sucrose). 
Finally, aniracetam pretreatment potentiated responding on the ethanol-associated lever 
during a cue-induced reinstatement procedure. Taken together, these data suggest that 
enhanced AMPA receptor signaling selectively contributes to facilitate ethanol self-
administration by potentiating both the reinforcing effects of ethanol and the capacity of 
ethanol-related cues to promote relapse of ethanol-seeking behavior. 
The reinforcing effect of drugs of abuse like alcohol is a major controlling process 
by which subsequent drug-taking episodes are facilitated (Stolerman, 1992; White, 
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1996). Here, a novel neuronal mechanism is provided that could contribute, in part, to 
increased ethanol drinking. That is, enhanced glutamate activity at AMPA receptors 
alters ethanol reinforcement processes in a manner that facilitates self-administration. 
These data are highly relevant given that excessive ethanol consumption has been 
shown to increase the likelihood for the development of alcoholism and/or alcohol 
dependence in humans (Saha et al., 2006). Interestingly, previous work by Stephens 
and Brown (1999) showed that administration of NBQX (AMPA receptor antagonist) not 
only reduced operant ethanol self-administration on a progressive ratio schedule of 
reinforcement, but sucrose and saccharin self-administration as well as locomotor 
activity; suggesting that AMPA receptors were either not selective in modulating ethanol 
reinforcement or results could not be determined due to non-specific motor-impairing 
effects of NBQX (Stephens and Brown, 1999). In contrast, the present work 
demonstrates a selective role for enhanced AMPA receptor activity in modulating 
ethanol reinforcement since AMPA receptor activation resulted in increased ethanol 
self-administration on a fixed ratio schedule of reinforcement. Further, reinforcer 
specificity was confirmed because aniracetam pretreatment was void of effects on 
sucrose self-administration.  
An intriguing feature of the ethanol self-administration experiments is the inverted 
U-shaped dose response curve following aniracetam pretreatment. Lower aniracetam 
doses were effective at significantly increasing operant self-administration, whereas 
higher doses did not alter ethanol-reinforced responses. This may reflect a response to 
changes in extracellular glutamate levels after chronic ethanol exposure. Specifically, 
low doses of aniracetam may have potentiated ethanol-induced excessive glutamate 
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levels and promoted ethanol self-administration, while higher aniracetam doses may 
have exceeded the necessary threshold to alter ethanol reinforcement or engaged other 
receptor signaling systems (e.g. loss of receptor specificity). Several studies show that 
chronic ethanol exposure increases extracellular glutamate levels as measured by in 
vivo microdialysis (Lallemand et al., 2011; Melendez et al., 2005; Roberto et al., 2004) 
in brain regions that have been shown to regulate ethanol reinforcement (Besheer et al., 
2010). Future investigations measuring glutamate levels/signaling after aniracetam 
pretreatment might assist in elucidating the underlying mechanism of this biphasic dose-
response effect.  
It could be argued that positive modulation of AMPA receptors induced changes 
in locomotor behavior that could have augmented operant responses. However, 
aniracetam pretreatment did not alter water or sucrose lever responding, and did not 
alter locomotor behavior in an open field, suggesting that increased ethanol self-
administration was not due to a treatment-induced hyperactive state. These findings are 
consistent with others showing that aniracetam does not alter locomotor behavior in rats 
(Ventra et al., 1994). Operant self-administration procedures have a critical learning and 
memory element (White, 1996) that could possibly have been influenced by aniracetam. 
Indeed, aniracetam is a nootropic compound that has cognitive-enhancing effects in 
rodents (Lebrun et al., 2000; Ventra et al., 1994). However, increased operant 
responding after aniracetam pretreatment did not generalize across reinforcers (i.e. no 
effect on sucrose self-administration), making an explanation of general enhancement 
of cognitive function less plausible. An alternative explanation is that aniracetam 
produced an ethanol-like effect that primed further ethanol self-administration. This is 
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highly unlikely due to evidence suggesting that the actions of AMPA receptor positive 
modulators counteract those of ethanol. Specifically, ethanol has been shown to 
stabilize rapid sensitization of AMPA receptors after activation by glutamate 
(Moykkynen et al., 2003; Moykkynen et al., 2009), whereas  AMPA receptor positive 
modulators act as desensitization inhibitors (Tang et al., 1991); allowing for increased 
AMPA receptor current decay time and essentially opposing the actions of ethanol 
(Jones et al., 2008). Interestingly, the possibility of the opposition of the effects of 
ethanol by aniracetam may explain the increased ethanol self-administration. That is, 
aniracetam may blunt the subjective or interoceptive effects of consumed alcohol which 
may lead to greater ethanol self-administration (Besheer et al., 2012b; Hodge et al., 
2001). Future investigation assessing the role of AMPA receptor positive modulation on 
the discriminative stimulus effects of ethanol could provide insight into whether AMPA 
receptor positive modulators alter how ethanol is perceived. Regardless of the 
underlying mechanism, our findings demonstrate a novel role for enhanced activity at 
AMPA receptors in promoting ethanol self-administration.  
A prominent feature of alcoholism is excessive drinking interspersed with periods 
of abstinence and subsequent relapse episodes (Johnson, 2010; McLellan et al., 2000). 
Furthermore, exposure to ethanol-associated cues has been shown to trigger craving 
and relapse episodes in humans and preclinical models (Papachristou et al., 2012; 
Schroeder et al., 2008). The current data show that enhancement of AMPA receptor 
activity potentiates ethanol-seeking behavior after re-exposure to ethanol-associated 
cues during a response-contingent reinstatement procedure. Further, aniracetam did 
not alter responding during extinction, highlighting the role of the cue in driving ethanol-
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seeking behavior.  Due to a lack of effect of aniracetam on sucrose self-administration, 
the role of aniracetam in sucrose reinstatement was not tested.  Examining the 
contributions of AMPA receptor activity in modulating non-drug seeking behavior might 
provide insights for a specified role of these receptors in modulating relapse to alcohol.  
Several studies have shown that reducing glutamate signaling at AMPA receptors 
attenuates relapse to ethanol-seeking behavior after exposure to ethanol cues 
(Backstrom and Hyytia, 2004; Sanchis-Segura et al., 2006). We extend those findings 
by offering a novel role for enhanced AMPA receptor signaling in modulating cue-
induced ethanol-seeking. That is, enhanced AMPA receptor activity may have bolstered 
the ability of ethanol cues to promote ethanol-seeking behavior. Interestingly, previous 
studies show that a history of excessive ethanol consumption increases purported 
conditioned responses to ethanol cues in humans (Drummond, 2000; Papachristou et 
al., 2012). Accordingly, the aniracetam-induced potentiation of ethanol cue salience to 
promote ethanol-seeking could have been a major contributing factor in driving the 
observed increase in ethanol self-administration. These data are of particular 
importance given that the present results suggest a role for enhanced AMPA receptor 
activity in modulating both heightened ethanol self-administration and relapse to 
ethanol-seeking. The findings suggest that enhanced AMPA receptor signaling could be 
involved in promoting vulnerability to relapse episodes.   
The present data highlight the role of increased glutamate transmission in 
relapse-like behavior. Indeed, glutamate levels have recently been shown to be 
elevated in the nucleus accumbens and amygdala during ethanol-seeking behavior 
using a cue-induced reinstatement procedure (Gass et al., 2011). These findings are 
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intriguing and suggest that aniracetam may have potentiated an already-heightened 
glutamatergic state during reinstatement; a possibility that will be interesting for future 
work to address.  To date, it is not known if P-rats differentially express basal levels of 
AMPA receptors as compared to other strains, which could influence pharmacological 
response to aniracetam and affect behavioral outcomes. An assessment of AMPA 
receptor expression across strains could provide additional understanding of AMPA 
receptor sensitivity to aniracetam treatment. Future experiments using AMPA receptor 
positive modulators and antagonists targeting AMPA receptors in specific limbic regions 
that regulate reward and drug-seeking could provide critical information about the 
neuronal circuitry involved in modulating increased ethanol self-administration and 
potentiated reinstatement. Interestingly, the present data parallel other studies 
investigating the role of AMPA receptor neurotransmission in modulating relapse to 
other drugs of abuse, particularly cocaine. Indeed, microinjections of AMPA agonists in 
the nucleus accumbens have been shown to reinstate cocaine-seeking behavior 
(Cornish and Kalivas, 2000); which strongly suggest that AMPA receptor signaling may 
regulate drug-seeking across a variety of drugs of abuse.  
In conclusion, the present work provides strong evidence for the involvement of 
enhanced AMPA receptor activity in modulating both increased ethanol self-
administration and potentiated relapse-like behavior. These data suggest that enhanced 
synaptic strength (particularly enhanced AMPA receptor signaling) may be one of the 
key pathophysiological changes that produce a behavioral phenotype similar to that of 
an alcoholic (i.e, increased drinking and susceptibility to relapse). A better 
understanding of how enhanced glutamate activity at AMPA receptors plays a role in 
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ethanol abuse disorders will be critically important in elucidating the underlying 
mechanisms of alcoholism and for the development of glutamate-based therapeutics 
aimed at treating alcohol abuse disorders. Future preclinical studies examining the role 
of therapeutic compounds that target AMPA receptors on alcohol drinking behavior 
could demonstrate therapeutic promise. 
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Table 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Baseline self‐administration parameters (mean ± SEM) prior to test sessions.
Experiment Alcohol Lever 
Responses
Water Lever
Responses
Intake
(g/kg)
Alcohol Self-administration (n=9)
Prior to aniracetam 157.78 ± 20.96 7.44 ± 1.56 0.81 ± 0.11
Sucrose Self-administration 
(n=11)
Prior to aniracetam
(Sucrose Resp.)
142.18 ± 28.39 11.73 ± 4.79
Cue-induced Reinstatement 
Vehicle Group (n=8 ) 172.25 ± 11.61 0.88 ± 0.39 0.77 ± 0.05
Aniracetam Group(n= 7) 174.43 ± 25.60 3.00 ± 0.90 0.82 ± 0.13
Resp, Responses
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Table 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clearance Parameters Vehicle Group Aniracetam Group
BAC at 0 min (mg/dl) 101.04 ± 11.09 92.06 ± 11.06
Clearance Rate 
(mg/ml/min)
0.41 ± 0.04 0.38 ± 0.04
Clearance Time (min) 245.06 ± 6.24 242.03 ± 4.95
Vd / body weight (dl/g) 0.011 ± 0.001 0.012 ± 0.001
Area Under Curve (AUC) 11736.33 ± 1215.13 9185.67 ± 1392.29
Table 2. Alcohol Clearance Parameters After Aniracetam Pretreatment.
Vd, Volume of  distribution
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Figure 1. Positive modulation of AMPA receptors potentiates alcohol self-administration. 
(A) Pre-treatment with aniracetam (ANI; 1 and 5Ԝmg/kg, i.p.) significantly increased total alcohol-
, but not water-reinforced responses during operant self-administration sessions in P-rats (nԜ=Ԝ9) 
trained to self-administer alcohol (15%, v/v) versus water. (B) Increased cumulative alcohol-
reinforced responses became apparent early within the session and remained elevated 
throughout the entire session after ANI pre-treatment (5Ԝmg/kg). (C) Spontaneous locomotor 
activity in an open field was not altered in P-rats pre-treated with ANI (5Ԝmg/kg). Graphed values 
are expressed as meanԜ±Ԝstandard error of the mean. *PԜ<Ԝ0.05 versus vehicle (Tukey's post 
hoc) 
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Figure 2. Antagonism of AMPA receptors by DNQX pre-treatment blocks aniracetam-
induced increased alcohol self-administration. Administration of the AMPA receptor 
antagonist, DNQX, significantly reversed aniracetam-induced increased alcohol-lever 
responding in P-rats (nԜ=Ԝ9) trained to self-administer alcohol (15%, v/v). Graphed values are 
expressed as meanԜ±Ԝstandard error of the mean. *Indicates significant changes relative to pre-
treatment with vehicle (dH2O)Ԝ+Ԝvehicle (0.5% CMC). #Indicates significant changes relative to 
pre-treatment with vehicle (dH2O)Ԝ+Ԝ5Ԝmg/kg aniracetam (Tukey's post hoc). 
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Figure 3. Alcohol clearance is not altered by aniracetam pre-treatment. Pre-treatment with 
aniracetam (5Ԝmg/kg; n  =Ԝ6) did not affect blood-alcohol content (BAC) across time after 
intragastric (IG) administration of alcohol (1 g/kg; IG) versus vehicle treated P-rats (nԜ=Ԝ6). 
Graphed values are expressed as mean ± standard error of the mean. 
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Figure 4 Positive modulation of AMPA receptors does not alter sucrose self- 
administration. (A) Pre-treatment with aniracetam (ANI) did not alter total sucrose- or water- 
reinforced responses during operant self-administration sessions in P-rats (nԜ =Ԝ11) trained self-
administer sucrose (0.8%, w/v) versus water. (B) Aniracetam pre-treatment did not alter the 
pattern of sucrose-reinforced responses across the course of the self-administration session. 
Graphed values are expressed as meanԜ±Ԝstandard error of the mean 
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Figure 5. Positive modulation of glutamate activity at AMPA receptors potentiates cue-
induced reinstatement of alcohol-seeking behavior in P-rats. (A) Removal of response 
contingencies significantly reduced alcohol-associated lever responding over a period of 13 
consecutive days during the extinction phase (*PԜ<Ԝ0.05 versus water lever). (B) Responding on 
the alcohol-associated lever was potentiated (nԜ=Ԝ7–8 per group) after pre-treatment with 
aniracetam (5Ԝmg/kg) during a cue-induced reinstatement session. [*PԜ<Ԝ0.05 versus extinction; 
#PԜ <Ԝ0.05 versus reinstatement (vehicle)Ԝ]. Lever responding resulted in the illumination of an 
alcohol-associated cue light, but alcohol was not available during this test session. (C) 
Responding on the water-associated lever remained unaltered after aniracetam pre-treatment 
during the same reinstatement test session. Water-lever responding resulted the illumination of 
a water- associated cue light, but water was not available during reinstatement testing. Graphed 
values are expressed as meanԜ±Ԝstandard error of the mean (Tukey's post hoc) 
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CHAPTER 3: POTENTIATION OF AMYGDALA AMPA RECEPTOR ACTIVITY 
SELECTIVELY PROMOTES ETHANOL SELF‐ADMINISTRATION IN A 
CAMKII‐DEPENDENT MANNER 
 
Introduction  
The reinforcing properties of drugs of abuse such as ethanol, are key contributing 
elements that promote subsequent drinking episodes and determine potential abuse 
liability (Ator and Griffiths, 2003; Griffiths et al., 2003). Elucidating the underlying 
neuronal mechanisms of ethanol reinforcement is critical, as novel insights have the 
potential to offer a greater understanding of factors that influence excessive drinking 
and ethanol-seeking behavior. An increasing amount of evidence suggests that AMPA-
type glutamate (AMPA) receptors are important modulators of ethanol drinking 
behaviors (Backstrom and Hyytia, 2004; Cannady et al., 2013; Sanchis-Segura et al., 
2006; Stephens and Brown, 1999; Wang et al., 2012). AMPA receptors are ligand-gated 
ion channel receptors comprised of four subunits (GluA1-4) and mediate rapid 
excitatory glutamate neurotransmission (Bredt and Nicoll, 2003; Kessels and Malinow, 
2009). These receptors are involved in a variety of biological functions and 
dysregulation of AMPA receptors has been implicated in several neurological, 
psychiatric, and addictive disorders (Chourbaji et al., 2008; Kobylecki et al., 2013; 
Purgianto et al., 2013; Rakhade et al., 2012; Zhang and Abdullah, 2013).  
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Strengthening of synaptic function has been linked to increased AMPA receptor 
trafficking and signaling (Heynen et al., 2000; Luscher et al., 1999). Furthermore, 
repeated experience with ethanol leads to AMPA-receptor mediated neuroadaptations 
that enhance synaptic strength in brain regions known to regulate reward processes 
(Heikkinen et al., 2009; Stuber et al., 2008; Wang et al., 2010). Thus, ethanol-induced 
synaptic strengthening may functionally promote ethanol consumption through 
alterations in reinforcement processes. Moreover, recent studies have examined 
ethanol-induced alterations in AMPA receptor subunit expression within limbic regions. 
Specifically, GluA1 subunit expression is upregulated in both the ventral and dorsal 
striatum, after systemically administered ethanol (Wang et al., 2012) and chronic 
intermittent ethanol consumption (Neasta et al., 2010), respectively. Surface GluA1 is 
also upregulated in the amygdala after chronic intermittent ethanol vapor exposure 
(Christian et al., 2012). Collectively, these studies further highlight the ethanol-induced 
neuroadaptations in AMPA receptor expression and trafficking that are associated with 
synaptic strengthening. In addition to increased expression, AMPA receptor signaling 
can also be potentiated through post-translational modifications of AMPA receptor 
subunits. Indeed, intracellular kinases such as CaMKII have been shown to facilitate 
AMPA receptor signaling by phosphorylation of GluA1 subunits; consequently altering 
channel kinetics, function, and increased receptor trafficking (Derkach et al., 1999; Lu et 
al., 2010). However, no studies have examined ethanol-induced phosphorylation of 
AMPA receptor subunits after a history of ethanol self-administration.  
Recently, systemic enhancement of glutamate activity at AMPA receptors has 
been shown to facilitate ethanol self-administration and seeking-behavior, which 
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demonstrates that heightened activity at these receptors has the potential to augment 
ethanol reinforcement processes (Cannady et al., 2013). Although evidence suggests 
that enhanced AMPA receptor activity can promote ethanol reinforcement, it is not fully 
clear as to which brain regions modulate AMPA receptor-mediated potentiation of 
ethanol reinforcement. Regions such as the amygdala and the nucleus accumbens 
have well-defined roles in modulating alcohol consumption, reinforcement, and seeking 
behaviors (Besheer et al., 2010; Chaudhri et al., 2013; Rassnick et al., 1992; Schroeder 
et al., 2003; Schroeder et al., 2008). Yet it is unclear if localized potentiation of AMPA 
receptor signaling modulates ethanol self-administration within the amygdala or nucleus 
accumbens.  
Using a genetic rodent model of high ethanol preference, the alcohol–preferring 
P- rat (Bell et al., 2006a), the current study examined the functional role of enhanced 
glutamate activity at AMPA receptors within limbic brain regions to modulate ethanol 
self-administration. First, phosphorylation of the GluA1 AMPA receptor subunit was 
used as a maker to identify potential brain regions that might represent areas of 
potentiated AMPA receptor signaling as a consequence of a history of ethanol self-
administration. Guided by these results, we microinjected aniracetam (AMPA receptor 
positive modulator) to functionally assess brain regional involvement in AMPA receptor-
mediated modulation of operant ethanol self-administration. Control experiments 
evaluated aniracetam effects on reinforcer specificity, and alterations in locomotor 
behavior. Finally, we assessed whether intra-amygdala aniracetam-induced alterations 
in ethanol self-administration were dependent on CaMKII activity. 
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Materials and Methods 
Animals  
Adult male inbred alcohol-preferring P-rats (420 - 500 g prior to testing) were 
bred in-house and were derived from a line of breeders of the selected line of P-rats (5B 
substrain) that was originally provided in 1999 by Indiana University (courtesy of Dr. 
T.K. Li). This stock of inbred P-rats has been bred and maintained on-site at the 
University of North Carolina at Chapel Hill. Animals were pair-housed in Plexiglas cages 
and handled daily prior to any training procedures, and subsequently single-housed 
after surgeries (see below). Between sessions (unless mentioned otherwise), all rats 
had unlimited homecage access to food and water. The colony room was maintained on 
a 12 hour light/dark cycle (lights on at 7am). All procedures used were conducted in 
accordance with the National Institute of Health guidelines, and approved by the 
University of North Carolina Institutional Animal Care and Use Committee.  
 
Apparatus 
Self-administration Chambers. Sound-attenuating cubicles enclosed the operant 
conditioning chambers (Med Associates, Georgia, VT) used for self-administration 
testing. Each cubicle was equipped with an exhaust fan for ventilation which also 
functioned to mask external sounds. Each operant conditioning chamber (measuring 
30.5 x 24.1 x 21.0 cm) contained a liquid receptacle adjacent to a response lever on the 
left and right wall of each chamber. Lever press responses activated a syringe pump 
(Med Associates) that delivered 0.1 ml of solution into the receptacle over 1.66 
seconds. A stimulus light located above each response lever was simultaneously 
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illuminated during pump activation and signaled reinforcer delivery. Lever responses 
during reinforcer delivery were recorded, but did not produce programmed 
consequences. All chambers were interfaced (Med Associates) to a single computer 
programmed to control sessions and record data.  
Locomotor Chambers.  Clear Plexiglas chambers (43.2 cm x 43.2 cm; Med 
Associates) were used to assess locomotor activity. Horizontal distance traveled (cm) 
was determined from the number of photobeam breaks and collected via computer 
interface  in 2 min time intervals using Activity Monitor software (Med Associates).  
 
Operant Self-administration  
Training. Prior to the first training session, rats were fluid-restricted for 
approximately 24 hrs. Immediately afterwards, rats were placed in the operant 
conditioning chambers for an initial 16-hr lever-press training session in which 
presentation of a 0.1 ml solution of concurrently available sucrose (10 %, w/v) and water 
was contingent on lever responses. Lever responses were initially maintained on a 
concurrent fixed-ratio 1 (CONC FR1 FR1) schedule of reinforcement and were gradually 
increased to CONC FR2 FR2 after delivery of 4 reinforcers, and then further increased 
to CONC FR4 FR4 after delivery of 10 reinforcers. All reinforcer deliveries were paired 
with a cue light located above each response lever. After completing the initial 16 hr 
training session, rats were returned to their homecage for a period of 24 hrs in which 
access to water was returned and remained available ad libitum thereafter.  
Sucrose Fading and Baseline Sessions. Next, rats began daily (Monday–Friday) 
30-min sessions (CONC FR4 FR4) where the sucrose concentration was gradually 
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decreased and ethanol concentration was increased using a modified sucrose-fading 
procedure (Samson, 1986) as previously described (Besheer et al., 2010; Cannady et 
al., 2013; Hodge et al., 1993b). Briefly, ethanol was gradually added to the 10% (w/v) 
sucrose solution and sucrose was gradually faded out so that ethanol (15%, v/v) alone 
maintained lever pressing. The specific order of mixed ethanol exposure was as follows: 
10% sucrose/2% ethanol (10S/2E), 10S/5E, 10S/10E, 5S/10E, 5S/15E, 2S/15E, 
0S/15E. There were 2 sessions at each concentration (i.e., 12 total sucrose fading 
sessions). Sucrose-trained P-rats did not receive ethanol and were faded to 0.4% (w/v) 
sucrose. The exact order of sucrose fading was as follows: 10S, 5S, 2S, 1S, 0.8S, 0.6S, 
0.4S. The final sucrose concentration was 0.4% (w/v) sucrose because this 
concentration produced similar lever responding as compared to the 15% ethanol-
trained animals. After the sucrose fading procedure, rats had a minimum of 28 baseline 
operant self-administration sessions with 15% ethanol vs. water (ethanol-trained P-rats) 
or 0.8% sucrose vs. water (sucrose-trained P-rats).  
 
Experiment 1: Examination of GluA1 phosphorylation (pGluA1) after chronic 
ethanol self-administration 
To examine the effects of chronic ethanol self-administration on expression and 
post-translational modifications of the GluA1 subunit, two groups of P-rats were trained 
to self-administer either ethanol (15% v/v) or sucrose (0.4%, control subjects) over 28 
baseline sessions. Immediately following the 28th session, P-rats were deeply 
anesthetized and brain tissue was fixed via transcardial perfusion by infusing sodium 
phosphate (0.1 M) followed by 4% paraformaldehyde at 4°C. Brains were extracted, 
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processed and frozen at -20°C. Next, brains were sliced into 40 micrometer sections 
using a freezing microtome and placed in cryoprotectant for later analysis by 
immunohistochemistry (IHC).  
Sections were immunolabeled by rabbit polyclonal anti-phospho GluA1 (Serine 
831) antibody (Phospho Solutions) or rabbit polyclonal anti-GluA1 (Millipore) antibody 
using DAKO Polymer HRP-Labeled anti-rabbit secondary antibody (DAKO). 
Phosphorylated and total GluA1 were visualized by diaminobenzidine solution (DAKO). 
Sections were then counterstained with toluidine blue (Fisher Scientific), mounted on 
glass slides and cover-slipped for analysis by light microscopy.  
As previously described in (Cannady et al., 2012; Spanos et al., 2012), images 
were captured using a digital camera (Regita model, QImaging, Burnaby, BC) mounted 
on an Olympus CX41 light microscope (Olympus America, Center Valley, PA) and 
interfaced to a computer (Dell, Round Rock, TX). Total- and pGluA1 immunoreactivity 
was quantified with image analysis software (Bioquant Nova; R&M Biometric, Nashville, 
TN). The microscope, camera, and software were background corrected and 
normalized to preset light levels to ensure fidelity of data acquisition. GluA1 and pGluA1 
pixel count measurements were calculated from a circumscribed field based on the 
brain region and divided by the area of the region, expressed as pixels/mm2. The 
researcher conducting the analysis was blind to the treatment conditions. Data were 
acquired from subregions of the amygdala (lateral, basolateral, and central nuclei), 
subregions of the nucleus accumbens (core and shell), the prefrontal cortex, and the 
dorsal medial striatum.    
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Experiment 2: Examination of site-specific positive modulation of glutamate 
activity at AMPA receptors on ethanol self-administration. 
Cannulae implantation. Stereotaxic surgery was performed in self-administration-
trained rats for site-specific infusion of the AMPA receptor positive modulator, 
aniracetam, to test whether region-specific potentiation of AMPAR signaling might 
influence ethanol reinforcement processes. Bilateral guide cannulae (26-gauge; Plastics 
One, Roanoke, VA) were implanted into the nucleus accumbens (core) and the 
amygdala (CeA). The coordinates for the nucleus accumbens and amygdala were AP 
+1.7, ML +1.5Ԝmm, DV −5.5Ԝmm, and AP −1.9, ML +4.2, −6.5 DV (from dura), 
respectively (Paxinos and Waton, 1998). No attempt was made to functionally 
distinguish effects in specific sub-nuclei of the accumbens (eg, core vs shell) or 
amygdala (eg, CeA, BLA, or LaDL) due to the volume of fluid injected and evidence that 
suggests that the distance of drug diffusion after microinjection could possibly be 
greater than the distance between each sub-nuclei (Perez de la Mora et al., 2006). Rats 
were given 1 week for recovery before resuming ethanol self-administration sessions.  
Ethanol self-administering P-rats were microinjected with aniracetam into the 
amygdala (0, 1, 3, µg/ 0.5 µl/side; n = 10) or nucleus accumbens (0, 1, 3, 6 µg/ 0.5 
µl/side; n = 11) prior to operant ethanol (15% v/v) self-administration sessions (30-min). 
Microinjected aniracetam doses within this range have been shown to be effective at 
altering behavior in previous studies (Masuoka et al., 2008; Rao et al., 2001). Site-
specific bilateral microinjections were made with 1.0Ԝμl Hamilton syringes connected to 
33-gauge injectors (Plastics One, Roanoke, VA) extending 2Ԝmm below the guide 
cannulae. An infusion pump (Harvard Apparatus, Natick, MA) delivered a volume of 
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0.5Ԝμl/side for 1Ԝmin and injectors were left in place for an additional 1.5Ԝmin to allow for 
diffusion. Rats began operant self-administration testing immediately following 
microinjections. Testing was conducted using a within-subjects design in which each 
aniracetam dose was administered in a randomized order. Blood-ethanol concentration 
measurements were not conducted after drug test sessions due to potential disruption 
of ongoing self-administration. There were at least 2 self-administration sessions 
between microinjections and test sessions occurred no more than two times per week. 
Additionally, each liquid receptacle in the operant chambers was monitored for residual 
fluid after every session.  
 
Experiment 3: Test for intra-amygdala aniracetam-induced alterations in 
locomotor behavior.  
Ethanol-trained P-rats (n = 9) were tested to examine if aniracetam-induced 
potentiated ethanol self-administration was the result of changes in locomotor activity. 
Animals received intra-amygdala microinjections of aniracetam (0 and 1 µg/0.5µl/side) 
prior to placement in locomotor chambers where distance traveled was measured and 
recorded via photo beam breaks. All rats experienced two 30-minute locomotor 
sessions in which aniracetam dose order (0 and 1 µg/0.5µl/side) was randomized. 
Locomotor sessions were interspersed with self-administration sessions where 
appropriate with at least 3 days between tests. Self-administration sessions were 
withheld on days of the locomotor tests. One rat was not able to be tested for locomotor 
behavior due to clogged guide cannulae; however, data for self-administration sessions 
were still included in data analysis.   
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Experiment 4: Test for reinforcer specificity via sucrose-self-administration. 
To test if enhanced AMPAR activity within the amygdala was selective at 
modulating ethanol reinforcement, sucrose-trained P-rats (n = 9) were microinjected 
with aniracetam (0, 1, 3, 6 µg/ 0.5µL/ side,) immediately before operant sucrose (0.4%, 
w/v) self-administration sessions (30-min). Aniracetam testing was conducted as 
described for the ethanol self-administration tests sessions.  
 
Experiment 5: Examination of CaMKII involvement in aniracetam-induced 
potentiation of ethanol self-administration 
To test if inhibition of CaMKII phosphorylation reduced ethanol self-administration 
P-rats (n = 7) received intra-amygdala microinjections with Myristolated Autocamtide-2-
related inhibitory peptide (mAIP; 0, 5, 10, 20 µg/ 0.5µL/ side,) immediately before 
operant ethanol (15%, v/v) self-administration sessions (30-min). A second group of 
ethanol-trained P-rats (n = 9) received intra-amygdala microinjections of vehicle, 
aniracetam (1 µg), AIP 10µg, and a cocktail solution consisting of aniracetam (1 µg) and 
AIP 10µg to test if aniracetam-induced alterations in ethanol self-administration were 
dependent on CaMKII activity. All microinjections were administered in a randomized 
order using a within subjects design. 
 
Drugs.  
Ethanol (95% (w/v); Pharmco-AAPER, Shelbyville, KY) was diluted in distilled 
water to 15% (v/v). Aniracetam (Tocris, Ellisville, Missouri) and myristolatred AIP (myr-
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AIP); Enzo Life Sciences) was dissolved in 50% DMSO in artificial cerebral spinal fluid 
(ACSF).  
Data Analysis 
Ethanol- (or sucrose-) responses were analyzed by one-way ANOVA. 
Cumulative responses, and cumulative distance traveled (cm) were analyzed by two-
way repeated measures analysis of variance (RM ANOVA). Tukey post-hoc 
comparisons were performed to identify differences between treatments/treatment 
groups. T-tests were performed to identify differences in pGluA1 and total GluA1 
immunoreactivity between ethanol- and sucrose self-administering rats within brain 
regions. Statistical significance was determined at p ≤ 0.05. 
 
Results 
Experiment 1: Examination of GluA1 phosphorylation (pGluA1) after chronic 
ethanol self-administration. 
To examine chronic ethanol–induced neuroadaptations of AMPA receptor 
subunits, immunohistochemistry (IHC) was performed to assess phosphorylation and 
expression of the GluA1 subunit in tissue from two groups of rats that experienced 28 
ethanol or sucrose self-administration sessions. Mean baseline values for ethanol- and 
sucrose-reinforced responses over 28 days of self-administration were 110.90 ± 11.31 
and 152.20 ± 28.35, respectively (Fig 6A and 6B). Although sucrose-trained P-rats 
showed a trend for increased lever responses, a comparison of 28-day mean baseline 
values did not reveal statistically significant differences between ethanol- and sucrose-
reinforced responses. Mean values for ethanol- and sucrose-reinforced responses on 
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the final (28th) day of self-administration sessions were 112.67 ± 14.85 and 119.00 ± 
29.50, respectively (Figure 6A and 6B). A comparison of mean baseline values on the 
final day of self-administration sessions did not reveal statistically significant differences 
between ethanol- and sucrose-reinforced responses. Together, these data indicate that 
reinforced behavior was similar between both ethanol and sucrose self-administering P-
rats, allowing for direct comparisons of GluA1 immunoreactivity between the two 
groups. 
 In the amygdala, pGluA1 immunoreactivity (IR) was significantly altered in two 
subregions: the central (CeA) and basolateral (BLA) nuclei. Specifically, pGluA1 IR was 
significantly increased in the basolateral (t(16)= 3.671, p=0.002; Figure 7A) and central 
(t(16)= 2.173, p=0.045, Figure 7B) nuclei of the amygdala in rats with a history of 
ethanol self-administration. In contrast, pGluA1 IR in the lateral nucleus of the amygdala 
(LA) did not vary between groups (Figure 7C). In the ethanol self-administration group, 
pGluA1 IR was significantly increased in the nucleus accumbens core (t(15)= 2.554, 
p=0.022, Figure 8A), but not the nucleus accumbens shell relative to the sucrose self-
administration group (Figure 8B). pGluA1 immunoreactivity in the dorsal medial 
striatum and prefrontal cortex was also examined, however, no statistical differences 
were observed between groups (Table 3). Additionally, amygdala total GluA1 
expression was measured to determine if alterations in phosphorylated GluA1 were the 
result of changes in subunit expression. No significant differences were observed in 
total GluA1 expression within the lateral, basal lateral, or central nuclei of the amygdala 
or the nucleus accumbens core and shell (Table 4). These data suggest that ethanol 
self-administration produces neuroadaptations (i.e. phosphorylation of GluA1 subunits) 
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within the amygdala and nucleus accumbens that may be associated with facilitated 
AMPA receptor signaling.  
 
Experiment 2: Examination of site-specific positive modulation of glutamate 
activity at AMPA receptors on ethanol self-administration. 
To assess whether potentiation of AMPA receptor activity within limbic brain 
regions would alter ethanol self-administration, aniracetam (AMPA receptor positive 
modulator) was microinjected into the amygdala or nucleus accumbens of P-rats trained 
to self-administer ethanol (15% v/v). Analysis by one-way RM ANOVA indicated that 
intra-amygdala infusion of aniracetam significantly increased ethanol-reinforced lever 
responding [F(2, 9) = 4.2, p < 0.03] (Figure 9A). Tukey post-hoc analysis showed a 
significant increase in ethanol lever responding with a low dose of aniracetam (1 µg) 
relative to vehicle treatment (p=0.03). Additionally, cumulative ethanol-reinforced 
responses were examined to determine the pattern of responding over time (30 min) 
during test sessions (Figure 9B).  Post-hoc analysis indicated a significant main effect 
of intra-amygdala aniracetam dose [F(2,18) = 3.78, p = .04] at 25 minutes and 30 
minutes, and a significant main effect of time  [F(5,45) = 26.88,  p < 0.001] as ethanol 
reinforced responding increased over the duration of the test sessions. However, there 
was no significant interaction of aniracetam dose and time.  
In contrast to intra-amygdala testing, intra-accumbens infusion of aniracetam did 
not significantly alter ethanol-reinforced responding across the tested doses (Figure 
10A). An analysis of the pattern of responding over time by two-way RM ANOVA 
showed a significant main effect of time [F(5,50) = 30.93, P <0.001], a significant main 
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effect of intra-accumbens aniracetam dose [F(3,30) = 3.85, P =0.02], but no significant 
interaction was observed (Figure 10B).  
 
Experiment 3: Test for intra-amygdala aniracetam-induced alterations in 
locomotor behavior.  
An examination of locomotor activity in an open field was performed to test if the 
dose of intra-amygdala aniracetam (1 µg) that caused a significant increase in ethanol 
reinforced-responding (Figure 9A) altered general locomotor behavior (Figure 11). 
Analysis of locomotor behavior after intra-amygdala aniracetam treatment by two-way 
ANOVA showed a significant main effect of time [F(14,112) = 169.49, P < 0.001], but no 
significant main effect of intra-amygdala aniracetam dose and no significant interaction. 
These data suggest that the observed increase in ethanol-reinforced responses was not 
the result of intra-amygdala aniracetam effects on locomotor behavior.   
 
Experiment 4: Test for reinforcer specificity via sucrose-self-administration.   
To determine if the observed increase in ethanol self-administration after intra-
amygdala aniracetam treatment (Figure 9) was specific to ethanol, sucrose (0.4%) self-
administering P-rats were microinjected with aniracetam into the amygdala prior to test 
sessions. Intra-amygdala aniracetam had no significant effect on sucrose-reinforced 
responses during 30-minute self-administration sessions across all tested doses 
(Figure 12A). An analysis of the cumulative sucrose-reinforced responses over time 
showed a main effect of time [F(5,40) = 13.53, P < 0.001], but no significant main effect 
of intra-amygdala aniracetam dose and no significant interaction (Figure 12B). These 
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data suggest that intra-amygdala aniracetam effects to increase ethanol self-
administration are specific to ethanol and not non-drug reinforcers.    
 
Experiment 5: Examination of CaMKII involvement in aniracetam-induced 
potentiation of ethanol self-administration 
To determine if aniracetam-induced increased lever responding was dependent 
on activation of CaMKII, the CaMKII peptide inhibitor, myr-AIP, was infused into the 
amygdala prior to ethanol self-administration sessions. First, a dose-response curve 
was generated with myr-AIP alone.  Analysis by one-way RM ANOVA indicated that 
intra-amygdala infusion of AIP significantly decreased ethanol-reinforced lever 
responding [F(3, 18) = 3.92, p = 0.03] as post-hoc analysis indicated that ethanol-
reinforced lever responding was significantly reduced by a 20 µg dose of AIP (p= 0.03; 
Figure 13A).  An examination of cumulative ethanol-reinforced responses over the 30-
min sessions indicated a significant main effect time [F(5,30) = 21.73,  p < 0.001]  and a 
significant interaction of AIP dose and [F(15,90) = 2.04, p = 0.02]. Post-hoc analysis 
indicated that ethanol-reinforced responding was significantly reduced by AIP (20 µg) at 
25 and 30 minutes (Figure 13B). Next, a cocktail of  the aniracetam dose (1 µg) that 
was effective at potentiating ethanol self-administration (Figure 9A) and the highest 
ineffective AIP dose (10 µg; Figure 13A), was tested to determine if aniracetam-
induced potentiation of ethanol self-administration was dependent on CaMKII activity. 
Significant differences in ethanol reinforced lever responding were observed after intra-
amygdala administration of the aniracetam-AIP cocktail [F(3, 24) = 12.52, p < 0.001]. 
Post-hoc analysis indicated that intra-amygdala infusion of aniracetam (1ug) alone 
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significantly increased ethanol-reinforced responses (p = 0.02; Figure 14), replicating 
the result from the previous experiment (Figure 9A), whereas intra-amygdala infusion of 
the aniracetam-AIP cocktail significantly reduced the aniracetam-induced increase in 
ethanol-reinforced lever responses (p < 0.001 ; Figure 14). Together these data 
indicate that aniracetam-induced increases in ethanol self-administration are dependent 
on amygdala CaMKII activity. 
 
Discussion 
Previously we have shown that acute systemic enhancement of glutamate 
activity at AMPA receptors facilitates ethanol reinforcement (Cannady et al., 2013). Data 
from this study extend those findings by providing evidence that potentiated activity of 
amygdala AMPA receptors promotes operant ethanol self-administration in a rodent 
model of high ethanol preference, the alcohol preferring P-rat. First, using 
immunohistochemistry (IHC), subregions of the amygdala and nucleus accumbens were 
identified as potential areas of enhanced AMPA receptor signaling as evidence by 
increased phosphorylation of GluA1 subunits in P-rats trained to self-administer ethanol 
relative to sucrose control subjects. These findings led us to target AMPA receptors in 
the amygdala and nucleus accumbens to determine functional involvement of enhanced 
activity of these receptors in potentiating ethanol reinforcement. Region-specific 
facilitation of ethanol reinforcement was determined as targeted potentiation of 
amygdala- but not accumbens-AMPA receptor activity by aniracetam increased ethanol-
self administration. Moreover, reinforcer specificity was confirmed as intra-amygdala 
aniracetam did not alter sucrose self-administration. Finally, enhanced AMPA receptor-
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mediated facilitation of ethanol reinforcement was dependent on activation of CaMKII as 
co-administration of myr-AIP and aniracetam blocked aniracetam-induced increases in 
ethanol self-administration. Taken together, these data provide novel insights into how 
enhanced AMPA receptor activity may exacerbate ethanol reinforcement.  
AMPA receptor activity is enhanced by several biological processes (Diaz, 2010; 
Partin et al., 1996; Pei et al., 2009) including phosphorylation at serine 831 of the GluA1 
subunit (pGluA1831). Here we show that a history of ethanol self-administration is 
associated with post-translational modifications that enhance AMPAR function within 
limbic brain regions. Specifically, significant up-regulation of pGluA1831 within the 
amygdala (BLA and CeA) and the nucleus accumbens (core) was observed relative to 
sucrose-self administering controls. Up-regulation of pGluA1831 is significant given that 
phosphorylation of serine 831 of the GluA1subunit  is associated with long-term 
potentiation (LTP; a molecular correlate of learning and memory) and facilitated 
trafficking of AMPA receptors to synaptic sites within the plasma membrane (Barria et 
al., 1997; Esteban et al., 2003), and suggests that chronic ethanol self-administration 
may be functioning to potentiate synaptic strength within these two well-characterized 
brain regions that regulate drug-taking and seeking behaviors. Future experimentation 
directly measuring alterations in synaptic strength in the amygdala and the nucleus 
accumbens during or after a history of ethanol self-administration are necessary to 
determine if this is a possibility.  
It might have been plausible that the ethanol-induced upregulation of pGluA1831 
was the result of increased GluA1 expression. However, this is unlikely as no significant 
changes were observed during an examination of total GluA1 immunoreactivity after a 
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history of operant ethanol self-administration (Table 2). These data are in contrast to 
recent studies that show upregulation of total GluA1 in the nucleus accumbens after 
ethanol exposure (Ary et al., 2012; Neasta et al., 2010). However, differences between 
previous findings and the current data are likely the result of methodological 
discrepancies as prior studies have not examined GluA1 expression using 
immunohistochemistry methods, or in the context of an operant behavior, or using 
sucrose as a control solution. It is plausible that GluA1 expression could be upregulated 
in sucrose-trained animals relative to subjects without exposure to a rewarding stimulus 
(i.e. no history of ethanol or sucrose) as evidenced by alterations in GluA1 subunit 
expression/trafficking after exposure to sucrose (Peng et al., 2011). An effect of up-
regulation of GluA1 in sucrose-trained rats could mask differences in GluA1 between 
ethanol and sucrose-trained subjects. Regardless, ethanol self-administering P-rats 
exhibit a greater degree of pGluA1 immunoreactivity providing novel evidence of 
ethanol-mediated alterations in AMPA receptor signaling in the amygdala and nucleus 
accumbens.  
Given that the amygdala and the nucleus accumbens were identified as possible 
areas of potentiated AMPA receptor signaling after ethanol exposure, we targeted these 
regions to examine the functional role of enhanced glutamate activity at AMPA 
receptors within these regions on the maintenance of ethanol self-administration. 
Potentiation of glutamate activity at amygdala AMPA receptors by a low aniracetam 
dose (1 μg) significantly increased ethanol-reinforced lever responses, suggesting that 
heightened signaling at AMPA receptors functionally modulates the reinforcing effects of 
ethanol. Furthermore, these data indicate that enhanced activity of amygdala AMPA 
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receptors contributed, at least in part, to our previous findings demonstrating that 
positive modulation of AMPA receptor activity facilitates ethanol self-administration 
(Cannady et al., 2013). Interestingly, only a low dose of intra-amygdala aniracetam 
potentiated ethanol-reinforced lever responses; consistent with previous findings 
observed when aniracetam was systemically administered prior to ethanol self-
administration (Cannady et al., 2013). Indeed, other studies have demonstrated an 
inverted U dose-response function by aniracetam (Pizzi et al., 1993).Together these 
data suggest that there may be a threshold for enhanced amygdala AMPA receptor 
activity to facilitate ethanol reinforcement . Further experimentation is warranted to test 
this hypothesis.  
AMPA receptors have previously been shown to modulate ethanol reinforcement 
and seeking behavior (Backstrom and Hyytia, 2004; Sanchis-Segura et al., 2006; 
Stephens and Brown, 1999). The current data support growing evidence demonstrating 
that the amygdala mediates operant ethanol self-administration (Economidou et al., 
2008; Funk et al., 2006; Roberts et al., 1996; Schroeder et al., 2003). To our 
knowledge, this study is the first to potentiate ethanol reinforcement via site-specific 
pharmacological manipulation of the amygdala; a brain region that has been historically 
associated with responses to aversive stimuli and ethanol-induced negative affect 
(Brown et al., 2013; Ming et al., 2013). Recent evidence has shown that potentiating 
activity of a specific BLA-accumbens circuit via optogenetic stimulation mediates 
motivated behavior as evidenced by increases in nose-poke-contingent self-stimulation 
(Stuber et al., 2011). Given this evidence, it might have been possible that potentiation 
of activity at amygdala AMPA receptors could alter reinforcement of a non-drug 
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reinforcer. However, sucrose self-administration was not altered by intra-amygdala 
aniracetam; which makes such an account less plausible. Previous evidence 
demonstrates that enhanced glutamate activity at AMPA receptors does not alter non-
drug reinforcement (Cannady et al., 2013) and is consistent with the current results as 
intra-amygdala aniracetam doses as high a 6 μg did not alter sucrose self-
administration. Future experimentation examining amygdala afferents and efferents 
could provide additional insights as to which neuronal pathways are critical for ethanol 
and non-drug reinforcement.  
 In contrast to the amygdala, positive modulation of glutamate activity at nucleus 
accumbens AMPA receptors by aniracetam did not significantly alter ethanol-reinforced 
lever responding; which suggests that potentiated activity of AMPA receptors to mediate 
ethanol reinforcement is specific to receptors in the amygdala. A slight trend for an 
increase in ethanol-reinforced lever responses was observed with a 3 µg dose of intra-
accumbens aniracetam, yet doses as high as 6 µg did not alter ethanol self-
administration. This lack of effect in the nucleus accumbens is surprising given the well-
established role for glutamate activity in this region to modulate ethanol reinforcement 
(Besheer et al., 2010; Rassnick et al., 1992). Recently, localized antagonism of AMPA 
receptors in the dorsal striatum was shown to reduce ethanol self-administration in a 
reinforcer specific manner (Wang et al., 2012). It would be interesting for future 
experimentation to examine the role of enhanced AMPA receptor signaling in the dorsal 
striatum, and other brain regions to map the neuroanatomical substrates that mediated 
increased ethanol self-administration.  
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Studies show that a history of ethanol exposure upregulates AMPA subunit 
proteins (Chandler et al., 1999; Neasta et al., 2010) in addition to increasing the 
expression of signaling molecules like calcium/calmodulin dependent protein kinase II 
(CaMKII) (Goulding et al., 2011; Lee and Messing, 2008; McBride et al., 2009). CaMKII 
which has been well-characterized for its role in enhancing AMPAR signaling by 
phosphorylating the AMPA receptor GluA1 subunit (Hayashi et al., 2000; Lee et al., 
2000; Malinow et al., 1989; Poncer et al., 2002; Tan et al., 1994). Given that we 
observed increases in phosphorylated GluA1 after a history of ethanol self-
administration and facilitated ethanol reinforcement by enhancing amygdala AMPA 
receptor activity, we tested whether the intra-amygdala aniracetam-induced increase in 
ethanol self-administration was dependent on CaMKII activity in the amygdala. Intra-
amygdala co-administration of myr-AIP and aniracetam reversed aniracetam induced 
increases in ethanol self-administration suggesting that AMPA receptor-mediated 
facilitation of ethanol reinforcement functions through a CaMKII-dependent mechanism.   
Along with previous findings, these data further demonstrate that enhanced 
activity of AMPA receptors might be involved in promoting excessive ethanol 
consumption; a factor linked to the risk of developing alcohol use disorder (Saha et al., 
2006).  These data suggest that AMPA receptors could be potential therapeutic targets 
to treat ethanol use disorders. Currently there are FDA-approved medications with 
actions to reduce activity at AMPA receptors, namely Perampanel (trade name 
Fycompa), an anti-epileptic compound (Hanada et al., 2011; Hsu et al., 2013). It would 
be interesting for future preclinical studies to examine the effects of this compound on 
ethanol drinking behaviors, including ethanol self-administration. Furthermore, given the 
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data from the present study, targeted reductions in CaMKII activity may also be of 
therapeutic value for treatment of ethanol use disorders. To date, there is no FDA-
approved medication with primary actions at CaMKII, but further preclinical testing with 
CaMKII compounds is warranted and may prove to be beneficial in treating drinking 
disorders.  
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Table 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Brain region Ethanol Self-
administration
Sucrose Self-
administration
Dorsal Striatum
pGluA1 IR
578061.14 ± 38087.65 512875.82 ± 41398.75
Prefrontal Cortex
pGluA1 IR
90755.45 ± 11676.13 95383.20 ± 10782.16
Table 3. pGluA1 immunoreactivity (pixels/mm2) after ethanol and 
sucrose self-administration. 
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Table 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Brain region Ethanol Self-
administration
Sucrose Self-
administration
BLA
Total GluA1 IR
278586.92 ± 15475.06 226075.41 ± 26978.66
CeA
Total GluA1 IR
279894.26 ± 19990.97 231786.97 ± 22227.42
LA
Total GluA1 IR
101791.44 ± 10195.63 78131.86 ± 16179.81
NAcb Core
Total GluA1 IR
537871.01 ± 34170.53 496885.22 ± 31824.75
NAcb Shell
Total GluA1 IR
556845.11 ± 42516.84 555220.79 ± 35620.06
Table 4. Total GluA1 immunoreactivity (pixels/mm2) after ethanol and 
sucrose self-administration. 
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Figure 6 Chronic ethanol and sucrose self-administration prior to immunohistochemistry. 
Total reinforced lever responses were measured across 28 baseline (A) ethanol- or (B) sucrose 
self-administration sessions prior to tissue collection for immunohistochemistry (IHC).Total 
reinforced responses are expressed as group means ± SEM. 
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Figure 7 Ethanol self-administration upregulates phosphorylation of the GluA1 AMPA 
receptor subunit in subregions of the amygdala. Chronic ethanol self-administration 
increased phosphorylation of the GluA1 subunit (at serine 831) relative to sucrose-trained P-rats 
as measured by increases in positive pGluA1 immunoreactivity (IR) in the (A) basolateral (BLA) 
and (B) central (CeA) nuclei of the amygdala. No differences were observed in the (C) lateral 
nucleus of the amygdala (LA). Representative photomicrographs (10X) are of pGluA1-IR after 
28 days of ethanol or sucrose self-administration. Graphed values are expressed as means ± 
SEM; *p<0.05 (t-test). 
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Figure 8 Ethanol self-administration upregulates phosphorylation of the GluA1 AMPA 
receptor subunit in subregions of the nucleus accumbens. Chronic ethanol self-
administration increased phosphorylation of the GluA1 subunit (at serine 831) relative to 
sucrose-trained P-rats as measured by increases in positive pGluA1 immunoreactivity (IR) in 
the (A) core, but not the (B) shell of the nucleus accumbens. Representative photomicrographs 
(20X) are of pGluA1-IR after 28 days of ethanol or sucrose self-administration. Graphed values 
are expressed as means ± SEM; *p<0.05 relative to vehicle treatment. 
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Figure 9 Positive modulation of amygdala AMPA receptors potentiates ethanol self-
administration. (A) Intra-amygdala aniracetam pretreatment (1 µg) significantly increased total 
ethanol-reinforced responses during operant self-administration sessions in P-rats (n = 10). (B) 
A main effect of aniracetam dose was observed at 25 and 30 mminute time points in an anlaysis 
of cumulative ethanol-reinforced responses with no significant interaction of time. Graphed 
values are expressed as means ± SEM; *p<0.05 relative to vehicle treatment. 
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Figure 10 Positive modulation of nucleus accumbens AMPA receptors does not alter 
ethanol self-administration. (A) Intra-accumbens aniracetam pretreatment (0 - 6 µg) did not 
significantly alter total ethanol-reinforced responses during operant ethanol self-administration 
sessions in P-rats (n = 11). (B) Cumulative ethanol-reinforced responses were not significantly 
altered by intra-accumbens aniracetam pretreatment. Graphed values are expressed as means 
± SEM. 
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Figure 11 Positive modulation of amygdala AMPA receptors does not alter locomotor 
activity. Spontaneous locomotor activity in an open field was not altered in ethanol self-
administration-trained P-rats (n = 9) after intra-amygdala aniracetam pretreatment (1 µg). 
Graphed values are expressed as means ± SEM. 
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Figure 12  Figure 7. Positive modulation of amygdala AMPA receptors does not alter 
sucrose self-administration. (A) Intra-amygdala aniracetam pretreatment (0 - 6 µg) did not 
significantly alter total sucrose-reinforced responses during operant ethanol self-administration 
sessions in P-rats (n = 11). (B) Cumulative sucrose-reinforced responses were not significantly 
altered by intra-accumbens aniracetam pretreatment. Graphed values are expressed as means 
± SEM. 
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Figure 13 Inhibition of amygdala CaMKII activity attenuates ethanol self-administration. 
(A) Intra-amygdala pretreatment with the CaMKII peptide inhibitor, myr-AIP (20 µg), significantly 
decreased total ethanol-reinforced responses during operant self-administration sessions in P-
rats (n = 7). (B) Cumulative ethanol-reinforced responses were significantly decreased by intra-
amygdala myr-AIP pretreatment (20 µg). Graphed values are expressed as means ± SEM; 
*p<0.05 relative to vehicle treatment. 
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Figure 14 Intra-amygdala inhibition of CaMKII activity blocks aniracetam-induced 
increased ethanol self-administration. Intra-amygdala co-administration of aniracetam (1 µg) 
and the CaMKII peptide inhibitor, myristolated AIP (10 µg), significantly reversed aniracetam-
induced increased ethanol-lever responses in P-rats (n = 9). Graphed values are expressed as 
means ± SEM; *p<0.05 relative to vehicle treatment. #p<0.05 relative to 1μg aniracetam (ANI). 
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CHAPTER 4: ROLE OF ENHANCED ACTIVITY AT AMYGDALA AMPA RECEPTORS 
IN MODUALTING RELAPSE-LIKE BEHAVIOR 
 
Introduction 
Relapse can be defined as “resumed binge drinking after a prolonged period of 
abstinence” (Becker). An enduring challenge for clinicians is identifying effective 
strategies and therapies that reduce the risk of relapse in patients with alcohol use 
disorder (Saitz et al., 2013). Indeed, risk for relapse after a period of abstinence has 
been estimated to be as high as 75% for individuals actively seeking treatment (Boothby 
and Doering, 2005).  Thus, researchers are focusing intensive efforts towards 
identifying the underlying mechanisms that govern relapse as this may lead to better 
treatment outcomes for individuals with alcohol use disorders.   
AMPA receptors are ionotropic glutamate receptors that allow for rapid excitatory 
signaling, which  facilitates the firing of action potentials through cellular depolarization 
(LoTurco et al., 1995). These receptors are of interest as they can mediate long-term 
changes in the strength of neuronal signaling (Nicoll and Malenka, 1995; Nicoll and 
Roche, 2013); an important concept as lasting neuroadaptive changes have been 
proposed to underlie susceptibility to relapse (Luscher and Malenka, 2011). AMPA 
receptors are heterotetramers, comprised of four subunits (GluA1-4) and post-
translational modifications of these subunits allows for diverse channel properties and 
modulation by intracellular signaling molecules (Lu et al., 2010; Lu and Roche, 2012). 
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Interestingly, expression of the GluA1 subunit of the AMPA receptor has been shown to 
be increased in limbic brain regions after extended periods of ethanol consumption (Ary 
et al., 2012; Neasta et al., 2010).  Moreover, AMPA receptors have been shown to 
mediate ethanol reinforcement and relapse-like behavior (Sanchis-Segura et al., 2006; 
Wang et al., 2012).  Indeed, we have shown that potentiation of AMPA receptor activity 
facilitates ethanol self-administration and relapse-like behavior; which suggest that 
enhanced AMPA receptor signaling may function as a maladaptive process in alcohol-
drinking behavior (Cannady et al., 2013).  
The amygdala is a key region of the brain known for its role in regulating 
associative learning processes (Cole et al., 2013; Gallagher and Holland, 1994; 
LeDoux, 2003). This region has been implicated in mediating drug-reward learning, as 
well as drug-cue associations (Cai et al., 2013; Hyman et al., 2006). Exposure to 
ethanol-associated cues has been shown to promote relapse in humans (Drummond, 
2000; Papachristou et al., 2012) and can be modeled by increased ethanol-seeking 
behavior in a cue-induced reinstatement procedure (Cannady et al., 2013; Ciccocioppo 
et al., 2003; Schroeder et al., 2008). Our previous study indicated that AMPA receptors 
in the amygdala play an important role in modulating ethanol reinforcement as 
evidenced by increased operant self-administration after localized positive modulation of 
amygdala AMPA receptors (Chapter 3). However, it is not known if relapse-like behavior 
is modulated in the same region-specific manner. Further, it is not clear if exposure to 
ethanol-associated cues produce adaptations in AMPA subunit expression that may 
indicate modified AMPA receptor activity. Given that we have established a role for 
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AMPA receptors in the amygdala for modulating alcohol drinking, we hypothesized that 
altering glutamate activity of amygdala AMPA receptors augments ethanol-seeking. 
Accordingly, we first examined alterations of AMPA receptor GluA1 subunit in the 
amygdala and nucleus accumbens after exposure to ethanol-associated cues following 
a response contingent cue-induced reinstatement procedure.  Next, the effects of acute 
pharmacological potentiation and inhibition of glutamate activity at amygdala AMPA 
receptors in modulating relapse-like behavior was examined. That is, in alcohol-
preferring p-rats the effects of intra-amygdala aniracetam (AMPA receptor positive 
modulator) or NBQX (AMPA receptor antagonist) were tested on cue-induced 
reinstatement after amygdala cannulae implantation. 
 
Materials and Methods 
Animals 
Male alcohol preferring P-rats (380 - 460 g prior to training) were obtained from 
Indiana University Medical Center. Rats were quarantined for approximately 6 weeks 
prior to testing. Animals were pair-housed in Plexiglas cages and handled daily prior to 
any training procedures, and subsequently single-housed after surgeries (see below). 
Between sessions (unless mentioned otherwise), all rats had unlimited homecage 
access to food and water. The colony room was maintained on a 12 hour light/dark 
cycle (lights on at 7am). All procedures used were conducted in accordance with the 
National Institute of Health guidelines, and approved by the University of North Carolina 
Institutional Animal Care and Use Committee. 
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Apparatus  
Self-administration Chambers. Operant conditioning chambers measuring 30.5 x 
24.1 x 21.0 cm (Med Associates, Georgia, VT) were located within sound-attenuating 
cubicles. Each cubicle was equipped with an exhaust fan for ventilation which also 
functioned to mask external sounds. The left and right wall of each chamber contained a 
liquid receptacle in addition to a response lever (i.e. two levers per chamber). Lever 
press responses activated a syringe pump (Med Associates) that delivered 0.1 ml of 
solution into the receptacle over 1.66 seconds. A stimulus light located above each 
response lever was simultaneously illuminated during pump activation. Lever responses 
during reinforcer delivery were recorded, but did not produce programmed 
consequences. The chambers were interfaced (Med Associates) to a computer 
programmed to control sessions and record data. 
 
Operant Self-administration  
Training. One day prior to training, rats were fluid-restricted for approximately 24 
hrs. Immediately afterwards, rats were placed in the operant conditioning chambers for 
an initial 16-hr lever-press training session in which presentation of a 0.1 ml solution of 
concurrently available sucrose (10 %, w/v) and water was contingent on lever 
responses. Lever responses were initially maintained on a concurrent fixed-ratio 1 
(CONC FR1 FR1) schedule of reinforcement and were gradually increased to CONC 
FR2 FR2 after delivery of 4 reinforcers, and then further increased to CONC FR4 FR4 
after delivery of 10 reinforcers. All reinforcer deliveries were paired with an illumination 
of a light cue located above each response lever. After completing the initial 16 hr 
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training session, rats were returned to their homecage for a period of 24 hrs in which 
access to water was returned and remained available ad libitum thereafter.  
Next, rats commenced daily (Monday–Friday) 30-min sessions (CONC FR4 FR4) 
where the sucrose concentration was gradually decreased and the ethanol 
concentration was increased using a modified sucrose-fading procedure (Samson, 
1986) as previously described (Besheer et al., 2010; Cannady et al., 2013; Hodge et al., 
1993b). Briefly, ethanol was gradually added to the 10% (w/v) sucrose solution and 
sucrose was gradually faded out so that ethanol (15%, v/v) alone maintained lever 
pressing. The exact order of mixed ethanol exposure was as follows: 10% sucrose/2% 
ethanol (10S/2E), 10S/5E, 10S/10E, 5S/10E, 5S/15E, 2S/15E, 0S/15E. There were 2 
sessions at each concentration (i.e., 12 total sucrose fading sessions). After the sucrose 
fading procedure, rats had a minimum of 28 baseline operant self-administration 
sessions with 15% ethanol vs. water. 
 
Examination of ethanol-associated cue exposure on expression of pGluA1  
After stable baseline responding, rats underwent extinction sessions (30 min) in 
which previously reinforced responses were extinguished over 12 consecutive days by 
removing response contingencies (i.e. no light cue or pump sound; no reinforcers 
delivered). On day 13, ethanol-trained P-rats were either given an additional extinction 
session (extinction group; n =15) or a reinstatement session (reinstatement group n = 
16). For the reinstatement group, lever responses (FR4) resulted in the presentation of 
the light cue and pump activation; however, no reinforcers (ethanol or water) were 
delivered. Note: 0.1 ml of the 15% ethanol (v/v) solution was added to the ethanol well 
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prior to the reinstatement session. This amount of ethanol (0.1ml) is not 
pharmacologically relevant and functioned to provide additional olfactory/taste cues to 
maximize lever responses during reinstatement (Backstrom et al., 2004; Cannady et al., 
2013). 
 
Western Blots 
Immediately following the reinstatement session (or extinction session for the 
extinction group) rats were anesthetized with isoflurane gas and brains were quickly 
removed and flash-frozen in an isopentane bath. Brains were stored at -80ºC for later 
processing by western blot analysis. As previously described (Besheer et al., 2010), 
brain tissue punches (1.2mm; UniCore, Sigma) of the amygdala and nucleus 
accumbens were taken from coronal sliced sections (thickness 1mm). Tissue was 
submerged in buffer (10mM Tris, 1% SDS, 1:100 Protease and Phosphatase Inhibitors) 
and homogenized (Branson Sonifier, Danbury, CT). After colorimetric detection and 
quantification (Pierce Biotechnology, Rockford, IL) of protein concentration, protein 
(10μg) was diluted with Sample Reducing Agent and LDS Sample Buffer (Invitrogen, 
Carlsbad, CA), boiled, and loaded onto a polyacrylamide gel (Biorad, Hercules CA) for 
separation by electrophoresis. Transfer of protein to a PVDF membrane (Invitrogen) 
occurred via dry blotting using iBlot (Invitrogen, Carlsbad, CA). Membranes were 
blocked in 3% normal goat serum (Vector Laboratories, Burlingame, CA) before 
overnight incubation at 4ºC in monoclonal rabbit anti-pGluA1831 (Millipore; 1:1000) and 
monoclonal mouse actin (Millipore; 1:5000) in blocking solution. Following incubation, 
membranes were washed and incubated 1h at room temperature in hrp-conjugated goat 
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anti-rabbit and anti-mouse secondary antibodies, respectively (Jackson 
Immunoresearch Labs, Inc.; 1:10,000). Protein expression was visualized using a 
chemiluminescent substrate (ECL; Pierce Biotechnology, Rockford, IL) before 
quantification using optical density measurements (GE software). Data were converted 
to percent actin for each blot and expressed as percent control (Extinction group). 
 
Examination of altered modulation of glutamate activity at amygdala AMPA 
receptors on regulating response-contingent cue-induced reinstatement. 
Cannulae implantation. As previously described (Besheer et al., 2010; Cannady 
et al., 2011), stereotaxic surgery was performed in self-administration-trained rats (15% 
ethanol vs. water; CONC FR4 FR4) for site-specific infusion of compounds to test 
whether pharmacological potentiation or inhibition of amygdala AMPAR signaling might 
alter ethanol-seeking behavior. Bilateral guide cannulae (26-gauge; Plastics One, 
Roanoke, VA) were aimed the the amygdala (CeA). The coordinates for amygdala were 
AP −1.9, ML +4.2, −6.5 DV (from dura) (Paxinos and Waton, 1998). Guides were 
implanted such that injectors penetrated tissue 2mm below the guide. We purposely 
made no attempt to functionally distinguish effects in specific sub-nuclei of the 
amygdala (eg, CeA, BLA, or LaDL) due to the volume of fluid injected and evidence that 
suggests that the distance of drug diffusion after microinjection could possibly be 
greater than the distance between each sub-nuclei (Perez de la Mora et al., 2006). Rats 
were given 1 week for recovery before resuming ethanol self-administration sessions.  
Reinstatement. After stable baseline responding, rats underwent extinction 
sessions (30 min) in which previously reinforced responses were extinguished over 13 
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consecutive days (as previously described (Cannady et al., 2013). Sham microinjections 
were conducted after extinction sessions to habituate rats to the microinjection 
procedure. During Sham injections, injectors did not penetrate brain tissue and no drug 
was infused. On the 13th day of extinction, all rats were microinjected with vehicle after 
their self-administration session to habituate the animals to receiving an infusion. 
Treatment groups were matched based on baseline response totals and extinction 
performance. On day 14, ethanol-trained P-rats were microinjected with vehicle (n = 9), 
aniracetam (1 μg; n = 10), or NBQX (1 μg; n = 11) immediately prior to a reinstatement 
session. As previously mentioned, lever responses (FR4) resulted in the presentation of 
the light cue and pump activation; however, no reinforcers (ethanol or water) were 
delivered.  
 
Drugs 
Ethanol (95% (w/v); Pharmco-AAPER, Shelbyville, KY) was diluted in distilled water to 
15% (v/v). Aniracetam (ABCAM Biochemicals, Cambridge, MA) and NBQX (Tocris, 
Ellisville, Missouri) were dissolved in 25% DMSO in aCSF. These doses were selected 
based on previous findings demonstrating alterations in ethanol self-administration 
(Chapter 3; (Wang et al., 2012).  
 
Data analysis 
Lever responses in the reinstatement sessions were analyzed by two-way RM 
ANOVA. T-tests were performed to identify differences in pGluA1 optical density 
between the reinstatement group and extinction group within brain regions. Differences 
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in pGluA1 optical density between the HR and LR (reinstatement group) and extinction 
group were analyzed by one-way ANOVA.  Ethanol lever responses for reinstatement 
tests examining drug effects by behavioral differences were analyzed by three-way 
ANOVA. Tukey post-hoc comparisons were performed to identify differences between 
treatments/treatment groups. Statistical significance was determined at p ≤ 0.05. 
 
Results 
Examination of ethanol-associated cue exposure on expression of pGluA1. 
P-rats were exposed to cues previously paired with ethanol in a reinstatement 
procedure to determine if exposure to these cues could promote phosphorylation of 
GluA1 and CaMKII. Only the reinstatement group displayed response contingent cue-
induced reinstatement of ethanol-seeking behavior, as evidenced by increased 
responding on the ethanol lever (Figure 15). Two-way RM ANOVA indicated significant 
main effects of cue exposure [F(1,56) = 11.77, P = 0.001] and test condition [F(1,56) = 
5.83, P < 0.02] and a significant interaction of cue exposure x test condition [F(1, 56) = 
19.16, p < 0.001].  Post-hoc analysis showed that the reinstatement group had 
significantly more lever responses on the ethanol-associated lever relative to their last 
extinction session (p < 0.001) and in comparison to the extinction group (p < 0.001).  
Brains were extracted immediately following the cue-induced reinstatement 
session to examine changes in pGluA1 expression.  An analysis of amygdala and 
nucleus accumbens pGluA1 expression did not reveal any significant differences 
between the reinstatement and extinction groups (Figure 16A and 16B). To assess 
whether behavioral differences during the reinstatement session could account for 
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alterations in phosphorylation of GluA1, the reinstatement group was divided into high 
responders (HR) and low responders (LR) based on their ethanol lever responses 
during reinstatement using a median split (30 responses). No differences were 
observed in GluA1 phosphorylation between HR/LR reinstatement responders relative 
to the extinction group (Figure 17A and 17B).  These data suggest that cue-induced 
ethanol-seeking is likely not associated with rapid GluA1 phosphorylation events in the 
amygdala or the nucleus accumbens.   
 
Examination of altered modulation of glutamate activity at amygdala AMPA 
receptors on regulating response-contingent cue-induced reinstatement. 
P-rats were microinjected with vehicle, aniracetam (1 μg), or NBQX (1 μg) in the 
amygdala prior to a cue-induced reinstatement procedure to determine if potentiation or 
inhibition of AMAP receptor activity altered cue-induced ethanol-seeking behavior. All 
treatment groups reinstated ethanol-seeking behavior as evidenced by increases in 
ethanol lever responding relative to the last day of extinction (Figure 18).  Two-way RM 
ANOVA indicated a significant main effects of test condition [F(1,54) = 67.63, P < 0.001] 
but no main effect of dose [F(2, 54) = 1.14, p = 0.33] or  significant interaction of dose x 
test condition [F(2, 54) = 1.65, p = 0.20].  To assess whether behavioral differences 
during the reinstatement session could account for alterations in response to drug 
treatment, treatment groups were divided into high responders (HR) and low 
responders(HR) using a median split. Three-way ANOVA showed a main effect of test 
condition [F(1,48) = 159.29, P < 0.001], an interaction of dose x behavior [(2,48) = 
24.26, P < 0.001], and an interaction of test condition x dose x behavior [(2,48) = 12.64, 
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P < 0.001]. Post-hoc analysis did not reveal a test condition x dose interaction at high (p 
= 0.13) or low level of behavior (p = 0.96). Together these data indicate that there was 
no significant effect of intra-amygdala aniracetam or NBQX on cue-induced 
reinstatement (Figure 19). 
 
Discussion 
Previous work showed that pharmacological enhancement of AMPA receptor 
activity potentiated ethanol reinforcement via actions within the amygdala (Chapter 3). 
This study sought to extend those findings by examining the role of ethanol-associated 
cues to alter expression of pGluA1; a plasticity-associated marker. Comparisons were 
made between rats that received a cue-induced reinstatement test relative to an 
extinction group. The reinstatement group exhibited robust ethanol-seeking behavior, 
but interestingly, no significant differences were observed in pGluA1 optical density 
measurements in the amygdala or nucleus accumbens of cue-exposed rats and 
extinction rats. Given that ethanol self-administration was increased after intra-
amygdala pretreatment with aniracetam, we examined the contribution of amygdala 
AMPA receptors to potentiate (aniracetam) or inhibit (NBQX) the expression of cue-
induced reinstatement. Although all treatment groups exhibited cue-induced 
reinstatement, there was no effect of intra-amygdala AMPA receptor potentiation or 
inhibition on cue-induced reinstatement. Together, these data do not suggest a 
prominent role for amygdala AMPA receptors in mediating relapse to ethanol-seeking.  
Based on our previous observation of increased pGluA1 expression after chronic 
ethanol self-administration (Chapter 3), we predicted that GluA1 phosphorylation would 
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be altered after exposure to ethanol-associated cues in a reinstatement procedure.  To 
our surprise, we observed no significant differences in pGluA1 expression after 
exposure to ethanol-associated cues. Given that these rats had a long history of cue-
ethanol pairings during training and self-administration sessions, it seems likely that 
they would have developed a strong learned association with the cues; detectable by 
changes in plasticity markers. However, alterations in pGluA1 were not evident. One 
possible explanation is that the time point that brains were extracted (immediately 
following the reinstatement session) was too short to detect changes in phosphorylation 
between groups. Others have shown alterations in expression of other markers such as 
c-fos after a reinstatement session; however, changes in c-fos expression occurred long 
after the session (90 min) (Dayas et al., 2007). An alternative to examining protein 
expression is to examine mRNA levels as transcription is a much more rapid process 
than translation and protein synthesis. Future studies will incorporate longer time points 
or an evaluation of transcripts after reinstatement. Additionally, other brain regions have 
to be examined to fully determine the extent of reinstatement-induced changes in 
pGluA1 expression. 
Our previous findings (Cannady et al., 2013) along with others (Backstrom and 
Hyytia, 2004; Sanchis-Segura et al., 2006) demonstrates AMPA receptor-mediated bi-
directional modulation of relapse-like behavior. That is, positive modulation of AMPA 
receptors promotes relapse-like behavior; while antagonism has opposite effects. 
Therefore, we examined both potentiation and inhibition of amygdala AMPA receptors in 
modulating cue-induced reinstatement. This approach allowed for maximal experimental 
outcome during a single test trial reinstatement session as opposed to administration of 
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two aniracetam or two NBQX doses (high and low) which may or may not have been 
effective with a limited testing window of one single microinjection per subject.  
Surprisingly, neither intra-amygdala aniracetam nor NBQX modulated ethanol-seeking. 
One factor that may have contributed to the lack of effect of aniracetam and NBQX is 
that doses may have been insufficient to alter reinstatement. Doses used within the 
current study were based on previous findings that 1 μg/ 0.5 μl is sufficient to alter 
ethanol self-administration (Chapter 3 and (Wang et al., 2012). Testing higher doses 
may have proven to be effective at altering reinstatement.   
Another factor that may have influenced the lack of effect of aniracetam or NBQX 
on reinstatement is the placement of cannulae. Indeed, cannulae were aimed at the 
central nucleus of the amygdala as this is the region is the site of aniracetam-induced 
ethanol self-administration (Chapter 3). Cannulae implantation in the BLA may have 
produced different results as this region has consistently been implicated modulating 
reinstatement of ethanol-seeking (Chaudhri et al., 2013; See et al., 2003). Indeed, 
recent studies have measured increased glutamate levels in this region in response to 
ethanol-associated cues (Gass et al., 2011). It may have been more appropriate to 
examine the role of the CeA in relapse to ethanol-seeking in response to stress as 
stress pathways are mediated by the CeA (Knapp et al., 2011; Koob, 2009). 
Furthermore, recent evidence demonstrates a selective role for the CeA, but not the 
BLA, in modulating stress-induced reinstatement as measured by a reduction in 
ethanol-seeking after administration of a glucocorticoid receptor antagonist (Simms et 
al., 2012). 
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The differences in IHC data (increased pGluA1) after ethanol self administration 
versus western blot analysis (no change in pGluA1) after reinstatement are intriguing. 
The divergence of pGluA1 response to ethanol or cues may suggest that pGluA1 is 
sensitive to ethanol experience as opposed to ethanol-associated stimuli. Replicating 
the changes (or lack thereof) in pGluA1 using both methodologies (IHC and western 
blot) will be key in determining if this is a possibility. As previously mentioned, it will be 
critical to test other brain regions to see if there is differential response to cues or 
ethanol experience.   
 Other brain regions are implicated in modulating relapse in response to alcohol 
stimuli. Evidence shows that glutamate activity in the nucleus accumbens modulates 
cue-induced ethanol-seeking (Sinclair et al., 2012). Further, others have shown 
increased c-fos expression in the nucleus accumbens after exposure to cues previously 
paired with ethanol (Jupp et al., 2011), which indicates that accumbens neurons are 
activated in response to ethanol-related cues. Although our previous findings do not 
indicate that enhanced glutamate activity in the accumbens modulates ethanol-self-
administration (Chapter 3), there still may be a role for this region in modulating cue-
induced ethanol seeking. Neuronal activation is also increased in the prefrontal cortex in 
response to ethanol-associated cues (Jupp et al., 2011); an intriguing finding, as the 
prefrontal cortex is activated in response to cues in humans and associated with 
increased vulnerability to subsequent relapse (Grusser et al., 2004). It would be 
interesting to see if enhanced AMPA receptor activity in the prefrontal cortex could 
promote cue-induced reinstatement. Future region-specific studies may reveal other 
targets that are sensitive to AMPA receptor mediated-increases in ethanol-seeking.    
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Figure 15 Cue-induced reinstatement of ethanol-seeking behavior in P-rats prior to 
western blot analysis. Responding on the ethanol-associated lever was potentiated in the 
reinstatement group (n = 16) relative to the extinction group (n = 15) after a response-contingent 
cue-induced reinstatement session. Lever responding resulted in the illumination of an ethanol-
associated cue light, but ethanol was not available during this test session.*P < 0.05 versus 
extinction group; #P < 0.05 versus last day of extinction. 
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Figure 16 Amygdala and nucleus accumbens pGluA1 expression after response-
contingent reinstatement. Response-contingent cue-induced reinstatement did not alter 
pGluA1(S831) expression in the reinstatement group (relative to extinction) as optical 
density(OD) measurements did not vary in the (A) amygdala or (B) nucleus accumbens (NAcb) 
of P-rats. Graphed values are expressed as pGluA1(S831) relative to beta actin as a 
percentage of the extinction group. 
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Figure 17 Amygdala and nucleus accumbens pGluA1 expression in high and low 
reinstatement group responders. Response-contingent cue-induced reinstatement did not 
significantly alter pGluA1(S831) expression in P-rats with high responses (HR) or low responses 
(LR) during  reinstatement (relative to extinction) as optical density(OD) measurements did not 
vary in the (A) amygdala or (B) nucleus accumbens (NAcb). Graphed values are expressed as 
pGluA1(S831) relative to beta actin as a percentage of the extinction group. 
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Figure 18 Potentiation or inhibition of glutamate activity at amygdala AMPA receptors 
does not alter cue-induced reinstatement of ethanol-seeking behavior. All treatment 
groups exhibited cue-induced reinstatement of ethanol seeking behavior. However, responding 
on the ethanol-associated lever was not altered by intra-amygdala aniracetam (1μg) or NBQX 
(1μg) pre-treatment (n = 9 – 11 per treatment group) during a cue-induced reinstatement 
session. White bars represent group ethanol lever response means on the last day of extinction. 
Filled bars represent group ethanol lever response means during reinstatement. Graphed 
values are expressed as group means ± SEM. 
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Figure 19 Potentiation or inhibition of glutamate activity at amygdala AMPA receptors 
does not alter cue-induced reinstatement in high or low reinstatement group responders.
All treatment groups exhibited cue-induced reinstatement of ethanol-seeking behavior. 
However, responding on the ethanol-associated lever was not altered by intra-amygdala 
aniracetam (1μg) or NBQX (1μg) pre-treatment (n = 4 – 7 per group) in high or low responders 
during a cue-induced reinstatement session. Graphed values are expressed as group means ± 
SEM. 
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CHAPTER 5: GENERAL DISCUSSION 
 
Repeated cycles of heavy drinking and subsequent relapse episodes are 
common features of alcoholism and alcohol use disorders (Johnson, 2010; McLellan et 
al., 2000). A challenge for researchers and clinicians is to identify novel pathways that 
mediate excessive drinking and vulnerability to relapse; as current medications are 
never effective in all patients seeking treatment for drinking problems (Miller et al., 
2011).  Increases in synaptic strength after chronic ethanol are proposed to modulate 
ethanol-related drinking behaviors (Cannady et al., 2013; McCool, 2010; Stuber et al., 
2011). Therefore we sought to determine if acute enhancement of glutamate signaling, 
particularly at AMPA receptors, could augment ethanol self-administration and relapse-
like behavior. Overall, results from the studies within this dissertation provide a novel 
role for enhanced glutamate activity at AMPA receptors in the facilitation of ethanol 
reinforcement processes and cue-induced ethanol-seeking behavior.    
First, positive modulation of AMPA receptors by systemically-administered 
aniracetam selectively increased ethanol- but not sucrose-reinforced lever responding in 
an operant self-administration procedure using P-rats; a rodent genetic model with a 
predisposition to consume ethanol (Bell et al., 2006a). Control studies indicated that 
increased ethanol self-administration was not the result of aniracetam-induced 
alterations in spontaneous locomotor behavior or ethanol clearance. Additionally, the 
role of AMPA receptors was confirmed as sytemic administration of an AMPA receptor 
104 
 
antagonist blocked aniracetam-induced increased ethanol self-administration. Further, 
positive modulation of AMPA receptor activity following systemic injection increased 
ethanol-seeking behavior during a response contingent cue-induced reinstatement 
procedure. Collectively, these studies suggest that enhanced glutamate activity at this 
receptor has a functional role in promoting drinking and cue-induced relapse-like 
behavior.  
Evidence that indicates that chronic ethanol potentiates synaptic strength in 
regions that mediate drinking behavior (Stuber et al., 2008). Therefore, we examined 
markers of increased synaptic plasticity associated with chronic ethanol self-
administration such as GluA1 phosphorylation (pGluA1) at Ser-831; as phosphorylation 
of this AMPA receptor subunit is linked with activity dependent enhancement of synaptic 
strength (Barria et al., 1997; Lee et al., 2000). Increased pGluA1 was observed in the 
amygdala (BLA and CeA) and the nucleus accumbens (core); brain regions well-
characterized for modulating ethanol-related behaviors.  Guided by these results we 
examined the functional role of enhanced glutamate activity at AMPA receptors within 
these brain regions by site-specific infusion of aniracetam. Intra-amygdala infusion 
increased ethanol self-administration in a region- and reinforcer specific manner; as 
intra-accumbens aniracetam had no effect on ethanol self-administration and intra-
amygdala aniracetam was void of effects in sucrose-trained P-rats. Importantly, we 
showed that the aniracetam induced increased in the amygdala in ethanol self-
administration was dependent on CaMKII activity. This finding is highly relevant as it 
provides a mechanism to account for aniracetam induced facilitation of ethanol 
reinforcement through actions within the amygdala.  
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Finally, given that we determined a functional role of enhanced AMPA receptor 
activity in the amygdala and potentiated ethanol-seeking after systemic aniracetam 
pretreatment, we next sought to determine the role of enhanced and inhibited activity of 
amygdala AMPA receptors in modulating cue-induced reinstatement. We hypothesized 
that intra-amygdala potentiation of AMPA receptor activity would promote ethanol-
seeking, while inhibition would attenuate ethanol-seeking. However, reinstatement of 
ethanol-seeking behavior was not altered by intra-amygdala administration of 
aniracetam or NBQX; suggesting that AMPA receptors in this region minimally 
contribute to cue-induced ethanol seeking.    
The amygdala is a key limbic brain region that shares reciprocal glutamatergic 
connections between the hippocampus, nucleus accumbens, and prefrontal cortex, 
while receiving primary dopaminergic inputs from the ventral tegmental area (VTA) 
(LeDoux, 2003) . These glutamatergic connections to the amygdala are important as 
they suggest that glutamate neurotransmission from these regions may be converging 
to influence effects observed with aniracetam-induced ethanol self-administration. Given 
that chronic ethanol exposure can increase extracellular glutamate levels (Lallemand et 
al., 2011; Melendez et al., 2005; Roberto et al., 2004), and  promote release of 
dopamine in the amygdala (Yoshimoto et al., 2000), conditions may be favorable for 
promoting sensitivity to ethanol reinforcement.  Recent evidence indicates that the 
nucleus accumbens may be critical in modulating amygdala-dependent alterations in 
reinforcement (Stuber et al., 2011). Further dissection of the circuits involved in 
modulating increased reinforcement will provide greater specificity as to which regions 
are contributing to amygdala-mediated reinforcement.  
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 Previous studies have decreased ethanol self-administration and relapse-like 
behavior by blocking activity at AMPA receptors (Backstrom and Hyytia, 2004; Sanchis-
Segura et al., 2006; Stephens and Brown, 1999). However, we extend those findings by 
providing novel evidence for bi-directional modulation of ethanol reinforcement and 
ethanol-seeking as positive modulation of AMPA receptors facilitated these behaviors. 
Others have also shown neurotransmitter receptor bidirectional regulation of alcohol 
drinking behavior. Indeed, the type 1 cannabinoid (CB1) receptor agonist and 
antagonist bi-directionally modulate operant ethanol self-administration; with only low 
doses of agonist potentiating ethanol-reinforced lever-responses (Malinen and Hyytia, 
2008). These data are similar to our findings as low doses of aniracetam increased 
ethanol self-administration. It may be interesting to determine if these two receptor 
signaling systems could work in concert to synergistically facilitate reinforcement. GABA 
agonists and antagonists have also been shown to bi-directionally regulate consumption 
(Boyle et al., 1993); however, bi-directional modulation of GABA receptors remains to 
be tested in an operant self-administration procedure. It is not known if other glutamate 
receptor subtypes can bi-directionally modulate ethanol reinforcement and ethanol-
seeking, but it will be interesting for future studies to address this possibility. 
Collectively, these data highlight the use of gain-of-function studies to help fully 
determine mechanisms related to drinking behavior.  
It is interesting that enhanced AMPA receptor activity in the amygdala, but not 
the nucleus accumbens modulated ethanol-reinforced lever responding. Several studies 
indicate that glutamate activity in the nucleus accumbens is important in modulating 
ethanol reinforcement. Indeed, intra-accumbens blockade of NMDA and mGluR5 
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receptors has been shown to reduced ethanol self-administration (Besheer et al., 2010; 
Gass and Olive, 2009; Rassnick et al., 1992). It may be that expression levels of AMPA 
receptors vary between the accumbens and amygdala and that a higher aniracetam 
dose in the accumbens is necessary to obtain effects on ethanol self-administration. 
However, this is unlikely as an intra-accumbens dose six times higher than that of the 
effective dose in the amygdala was ineffective at changing behavior. Based on the 
observed increase in pGluA1 expression as measured by immunohistochemistry in 
ethanol-trained rats, an alternative explanation is related to microinjection site. Several 
lines of evidence suggest discrete roles for each accumbens subregion (core vs shell) in 
mediating the rewarding properties of drugs of abuse (Chaudhri et al., 2010; Ito and 
Hayen, 2011). Future experimentation examining potentiated AMPA receptor signaling 
in the shell may produce different effects on ethanol self-administration. The same could 
be argued as to why intra-amygdala aniracetam or NBQX did not alter reinstatement as 
placements were aimed at the CeA. Multiple studies implicate the BLA in modulating 
cue-induced relapse (Gass et al., 2011; See et al., 2003). Thus, aiming guide cannulae 
in BLA has the potential to show differential effects as compared to the CeA. Moreover, 
by no means does our data implicate only the amygdala in mediating AMPA receptor 
modulation of ethanol effects. Several other brain regions express AMPA receptors 
(Petralia and Wenthold, 1992) and may be equally, if not more, involved in mediating 
ethanol reinforcement and relapse-like behavior.  
  Ethanol self-administration procedures allow for analysis of complex behavior, 
but are limited in that consumption levels are difficult to measure over extended periods 
of time. It would be interesting to investigate the effects of enhanced activity of AMPA 
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receptors in modulating chronic consumption of ethanol.  Alternatives would be to use 
two-bottle drinking procedures, or binge models to evaluate the effects of enhanced 
AMPA receptor signaling on those consumatory behaviors. However; an inherent 
limitation is that acute dosing is often not adequate to examine extended access to 
ethanol. Thus, chronic administration of aniracetam would likely be necessary to 
determine if enhanced activity at AMPA receptors promotes increased consumption.     
It is intriguing that positive modulation of AMPA receptor activity facilitates 
ethanol self-administration. Current data herein suggest that potentiated cue salience to 
ethanol-related stimuli after aniracetam pretreatment may partially explain increased 
self-administration. Yet, a limitation of the current study is that self-administration 
procedures do not fully explain mechanisms underlying behavioral changes. Other 
behavioral mechanisms may also account for the increase in ethanol self-
administration. For example, the interoceptive or discriminative stimulus effects of 
ethanol are proposed to be major controlling processes that regulate drug-taking as 
consumed ethanol produces distinct subjective cues by which the presence of ethanol is 
detected (Stolerman, 1992). Multiple glutamate receptor subtypes modulate the 
interoceptive effects of ethanol (Besheer et al., 2010; Cannady et al., 2012; Grant and 
Colombo, 1993; Hodge and Cox, 1998; Hodge et al., 2001); however, no studies to date 
have examined functional role of AMPA receptors in the expression of ethanol 
subjective properties. It could be that pretreatment with aniracetam might have altered 
the subjective effects of ethanol, thereby promoting increased drinking. Indeed 
increased ethanol self-administration has recently been associated with altered ethanol 
discriminative stimulus effects (Besheer et al., 2012b; Besheer et al., 2013). Moreover, 
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the amygdala is implicated in aniracetam-induced increased ethanol self-administration. 
Given that this region is well-characterized for modulating ethanol subjective effects 
(Besheer et al., 2003; Besheer et al., 2012a; Cannady et al., 2012; Hodge and Cox, 
1998), it could be interesting to see if systemic or brain region-specific enhanced activity 
at AMPA receptors alters the subjective cue.    
Another limitation of the current methodology is that it is difficult to determine the 
physiological mechanism(s) by which potentiation of AMPA receptor signaling is 
facilitating reinforcement and relapse-like behavior. The exact amount of potentiation of 
glutamate activity at AMPA receptors by administered aniracetam doses is difficult to 
determine in behaving animals, which is crucial as we observed inverted U-shaped 
dose-response curves following systemic and intra-amygdala aniracetam treatment 
during ethanol self-administration sessions.  These data suggest that the amount of 
potentiation of AMPA receptor activity by aniracetam is critically important in modulating 
behavior. Further experimentation in slice preparations after aniracetam treatment may 
allow for a better quantitative determination of AMPA receptor potentiation thresholds 
necessary to alter behavior.  
Aniracetam binds to AMPA receptors and acts as a potent desensitization 
inhibitor allowing for slower decay kinetics of glutamate-induced AMPA receptor current 
(Isaacson and Nicoll, 1991). Interestingly ethanol has been shown to inhibit AMPA 
receptor function by stabilizing desensitization of AMPA receptors (Moykkynen et al., 
2003). These data suggest that intra-amygdala aniracetam may be counteracting the 
actions of ethanol to stabilize desensitization and inhibit AMPA receptors. Indeed, other 
AMPA receptor positive modulators counteract the intoxicating effects of ethanol as 
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measured by attenuation of ethanol-induced motor impairment in various tasks (Jones 
et al., 2008). Thus desensitization inhibition may serve to reduce overall ethanol 
sensitivity; an interesting possibility for future studies to examine. Related to this point, it 
would be interesting to determine if there are endogenous substrates that function as 
AMPA receptor desensitization inhibitors and are modulated by ethanol.    
One of the key hallmarks of alcohol use disorders is the development of ethanol 
dependence. Dependence is often characterized by compulsive craving, increased 
tolerance, and physical withdrawal symptoms including: tremors, insomnia, 
hyperactivity, and anxiety (American Psychiatric Association, 2013). Our data indicate 
that enhanced AMPA receptor activity can promote increased self-administration of 
moderate doses of ethanol in non-dependent animals. However; it is not clear as to how 
potentiation of AMPA receptor activity would alter ethanol self-administration or relapse-
like behavior in a dependence model. Others have recently shown that glutamate 
receptor subtypes differentially modulate reinforcement and ethanol-seeking in 
dependent versus non-dependent rats (Sidhpura et al., 2010). Thus, it is possible that 
potentiation of AMPA receptor activity may function differently in a dependent rodent 
model; an interesting possibility for future experiments to examine. Furthermore, 
dependence and withdrawal have been associated with increased anxiety-like 
phenotypes; an effect attributed to maladaptive neuroadaptations within brain regions 
such as the amygdala (Roberto et al., 2010; Sparta et al., 2007; Wills et al., 2010). 
Studies indicate that AMPA receptor positive modulators may mediate anxiety-like 
behavior as indicated by alterations in response to fear-inducing stimuli in a fear-
conditioning procedure (Yamada et al., 2009).  Given that we observed behavioral 
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changes in this region after positive modulation of AMPA receptors, it may be possible 
that chronic ethanol induced-anxiety could be attenuated by aniracetam pretreatment.            
Effects were observed on the maintenance of ethanol self-administration and 
cue-induced reinstatement of ethanol-seeking behavior. However, the role of enhanced 
AMPA receptor activity in modulating ethanol-seeking during extinction was not fully 
examined. Others have recently shown that nootropic compounds may have some 
efficacy at promoting extinction learning, which could be important as a therapeutic tool 
to reduce sensitivity to drug-related cues (Kufahl et al., 2012).  Indeed, aniracetam is a 
nootropic drug with actions to promote learning and memory processes (Lebrun et al., 
2000; Vaglenova et al., 2008). As a control experiment, we tested whether aniracetam 
could potentiate ethanol-seeking during an extinction session, which resulted in no 
significant effect on ethanol lever responding. However, it is not clear if extinction 
learning can be facilitated by enhancing activity at AMPA receptors in the presence of 
ethanol-associated cues. Future experimentation by chronically administering 
aniracetam during cue-exposure would address this possibility. 
In conclusion, we have determined a functional role for enhanced activity of 
AMPA receptors to facilitate ethanol reinforcement and relapse-like behavior in an 
alcohol-preferring rodent model of alcoholism. These studies add to a small, yet 
growing, body of literature demonstrating the significance of AMPA receptor-mediated 
neuroadaptations and signaling in modulating various aspects of ethanol drinking. 
These data also highlight the role of potentiated glutamate signaling in promoting 
increased drinking and vulnerability to relapse and suggest that therapeutics targeting 
glutamatergic systems or AMPA receptors could be of significant clinical relevance.
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